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ABSTRACT 
Impact of Diabetes on Colorectal Cancer Outcomes 
Neel A. Shah 
Diabetes is one of the most common chronic comorbid condition seen in elderly CRC patients. 
Outcomes of CRC patients with diabetes specifically stage at diagnosis, emergency condition for 
CRC surgery, survival, and mortality have been insufficiently explored. The aims of the study 
were to investigate the association between diabetes and stage at diagnosis of CRC in elderly 
Medicare beneficiaries; to check the association of diabetes with presenting as an emergency 
condition for CRC surgery in the elderly and; to explore the effect of diabetes on survival of 
elderly Medicare beneficiaries with CRC. Using the SEER-Medicare data from 2003-2005, 
patients newly diagnosed with CRC were selected and divided into diabetic and nondiabetic 
cohorts. The two cohorts were compared in terms of stage at CRC diagnosis, emergency 
presentation for CRC surgery, and five year survival. Logistic regressions were used to check the 
association between diabetes and stage at diagnosis and emergency condition for CRC surgery. 
Survival analysis was employed compare time to death between diabetic and non-diabetic CRC 
patients. Covariates used in the study included the three most common comorbid conditions 
besides diabetes: coronary atherosclerosis, congestive heart failure, and chronic obstructive 
pulmonary disease, age, sex, race, tumor location, region in the country, patient location, and 
frequency of physician office visits. For survival analysis additional treatment variables – 
chemotherapy, radiation, and surgery were included. For stage at diagnosis of CRC, diabetes 
showed a significant inverse association (OR 0.92; 95% CI 0.85-1.00). On adding quintile of 
physician office visits this association was not significant.  Odds of being diagnosed at a later 
stage was significantly associated with the least number of office visits (OR 2.13; 95% CI 1.86-
2.44) as was having a proximal tumor (OR 1.40, 95% C 1.30-1.51) Although the odds of a 
diabetic patient being an emergency patient were lower than a non-diabetic, this was not 
statistically significant (OR 0.89; 95% CI 0.79-1.01) Mortality risk was significantly greater for 
diabetic CRC patients than nondiabetics (HR 1.15, 95% CI 1.09-1.20). Presenting emergently 
increased the risk of mortality (HR 1.61, 95% CI 1.54-1.68). Surgery for CRC reduced the risk 
of mortality (HR 0.41, 95% CI 0.39-0.43) and although in bivariate analyses patients who 
received chemotherapy were more likely to die, the hazard model showed a significant benefit 
associated with chemotherapy or radiation (HR 0.70, 95% CI 0.67-0.74). The worse terminal 
outcomes seen in diabetic CRC patients indicates the need for early and timely screening to 
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Colorectal cancer (CRC) is the third most common form of cancer after prostate/breast 
and lung cancer in men and women in the United States (Ahuja, Chang, & Gearhart, 2007) 
(Jemal, Siegel, Ward, Hao, Xu, & Thun, 2009). In 2011 approximately 141,210 men and women 
were expected to be diagnosed and approximately 49,380 are expected to succumb to CRC The 
incidence of CRC is uncommon under the age of 50 years and younger patients’ tumors are 
thought to predominantly be induced by heredity in those with a family history (Rim, Seeff, 
Ahmed, King, & Coughlin, 2009). However, the incidence of colorectal adenomas, which are 
precursors to the cancer, rises with age and two thirds of all CRC occur in patients over the age 
of 65 (Holt, Kozuch, & Mewar, 2009). 
 Although a definitive causal factor for CRC has not been identified, several risk factors 
have been hypothesized to lead to the cancer. These include family history and genetics,  
increasing age, male sex, previous colonic adenomas, and environmental factors such as 
consumption of red meat, high-fat diet, inadequate intake of fiber, sedentary lifestyle, smoking, 
high consumption of alcohol, diabetes mellitus and obesity (Centers for Disease Control and 
Prevention). A review of several studies with diverse endpoints and in diverse populations has 
shown that insufficient vitamin D has a causal association with CRC (Giovannucci E. , 2010). 
Inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease have also proven to 
be strongly associated with CRC, with one meta-analysis showing high a odds ratio (2.59) of 
developing CRC in Crohn’s disease patients (von Roon, Reese, Teare, Constantinides, Darzi, & 
Tekkis, 2007) (Eaden, Abrams, & Mayberry, 2001). 
 Early stage CRC can be asymptomatic. Symptoms that may appear as the cancer 
progresses include blood (either bright red or very dark) in the stool; diarrhea, constipation, or 
feeling that the bowel does not empty completely; stools that are narrower than usual; frequent 
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gas pains, bloating, fullness, or cramps; unexplained weight loss; fatigue; and nausea and 
vomiting. However, these symptoms are common to various other diseases/conditions and only 
pathologic abnormalities observed during screening for colorectal adenomas or tumors can 
confirm a diagnosis of cancer.  
 Staging of CRC is based on the TNM (Tumor, Node, Metastases) classification. Most 
colorectal cancers start off as adenomatous polyps that turn into adenocarcinomas (cancers that 
begin in cells that make and release mucus and other fluids). TNM classification is followed by 
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Table 1. TNM Classification of Colorectal Cancer 
T=primary tumour N=regional lymph nodes M=distant metastasis 
TX=primary tumour cannot be assessed NX=regional lymph nodes cannot 
be assessed 
MX=distant metastasis 
cannot be assessed 
T0=no evidence of primary tumour N0=no regional lymph node 
metastasis 
M0=no distant metastasis 
Tis=carcinoma in situ: intraepithelial or 
invasion of lamina propria 
N1a=metastasis in one regional 
lymph node 
M1a=distant metastasis to 
one site 
T1=tumour invades submucosa N1b=metastasis in two to three 
regional lymph nodes 
M1b=distant metastasis to 
more than one site 
T2=tumour invades muscularis propria N2a=metastasis in four to six 
regional lymph nodes 
 
T3=tumour invades through the muscularis 
propria into subserosa or into 
nonperitonealised pericolic or perirectal 
tissues 
N2b=metastasis in seven or more 
regional lymph nodes 
 
T4a=tumour penetrates the surface of the 
visceral peritoneum 
  
T4b=tumour directly invades or is 
histologically adherent to other organs or 
structures 
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Table 2. Colorectal Cancer staging based in TNM Classification 
 Stage I Stage II Stage III Stage IV 
TNM staging T1 N0 M0 
T2 N0 M0 
A: T3 N0 M0 
B: T4 N0 M0 
A: T1-2 N1 M0 
B: T3-4 N1 M0 
C: Any T N2 M0 
Any T Any N M1 






tissues (T3). Invades 
other organs or 
structures/visceral 
peritoneum (T4) 
Involves 1-3 (N1) or 
















95% 82% 57% 6% 
Source: (Gloeckler Ries, Reichman, Lewis, Hankey, & Edwards, 2003) 
 
 As many as 50% of the Western population develops adenomatous polyps in their 
lifetime but the lifetime risk for colon cancer is about 5% and only one in ten adenomas lead to 
cancer formation (Holt, Kozuch, & Mewar, 2009). It cannot be determined which individuals 
with adenomas (or a histologically normal colon at risk for adenoma and cancer formation) will 
develop a cancer, and therefore, preventive methods use detection and removal of benign 
neoplastic colorectal adenomas to lower colon cancer formation and mortality (Muller & 
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Sonnenberg, 1995). Timely screening can lead to early detection of the cancer, better prognosis 
of the disease and improved observed survival rates (Miller, 2008). The advantage that CRC 
screening has over screening for other types of cancer is that with the appropriate test it can 
detect and remove cancer precursors, such as, adenomatous polyps, to decreased the incidence 
(Mandel, Bond, & Church, 2000). 
 
Elderly and CRC 
The incidence of CRC increases with age and almost two-thirds of CRC cases occur in 
individuals over the age of 65. Molecular and pathophysiological evidence as to why there is an 
increase in CRC incidence with age in humans is vague (Holt, Kozuch, & Mewar, 2009). 
Relative survival rates from 1996-2000 have shown no significant difference between age groups 
up to 75 years, however after the age of 75 there is a decline in survival rates (Ries, Melbert, 
Krapcho, Stinchcomb, Howlader, & Horner, 2007). Although the overall incidence and mortality 
is similar in both sexes, the age specific incidence is greater in men. Colorectal adenomas and 
cancer appear several years later in women probably due to protection by estrogen/progesterone. 
Some studies have shown that postmenopausal estrogen/progesterone hormone treatment in 
women can lower colorectal neoplasia risk by as much as 30% (Johnson, et al., 2009) 
(Chlebowski, et al., 2004 ). Comorbidity, or illness other than the primary illness under 
treatment, is more common in the elderly (Shack, Rachet, Williams, Northover, & Coleman, 
2010 ). Older individuals also often present with chronic conditions that complicate the 
diagnostic and clinical management of CRC which leads to poorer prognosis and outcomes of 
the cancer (Yancik, et al., 1998 ) (Satariano & Silliman, 2003). The three most common 
comorbid conditions with CRC seen in elderly patients are congestive heart failure, chronic 
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obstructive pulmonary disease and diabetes mellitus (Gross, Guo, McAvay, Allore, Young, & 
Tinetti, 2006 ) 
 
Diabetes and CRC 
 There is a large body of literature contributing to evidence about the association of 
diabetes mellitus with CRC. Most studies exploring the relationship between diabetes and CRC 
have studied type 2 diabetes mellitus or have not separated type 1 and type 2 diabetes. 
Epidemiological studies that have included type 1diabetes have not found a significant 
association between type 1 diabetes and CRC (Wideroff, et al., 1997) (Zendehdel, Nyrén, 
Ostenson, Adami, Ekbom, & Ye, 2003). One of the first studies to document a high occurrence 
of diabetes mellitus in patients with colon cancer was published in 1984  by Williams and 
colleagues (Williams, Walsh, & Jackson, 1984). Their observation of excessive simultaneous 
occurrence of diabetes mellitus in patients with colon cancer in a private clinic was documented 
by a retrospective review of records in the clinics and their associated community hospital.  
 The first Cancer Prevention Study of the American Cancer Association, initiated in 1959, 
was a large prospective epidemiological study of colorectal cancer incidence in diabetic patients 
(Will, Galuska, Vinicor, & Calle, 1998). After following diabetics for 13 years and adjusting for 
known cancer risk factors they found that the increased risk of developing CRC compared to 
non-diabetics was 30% in men and 16% in women. Several subsequent prospective studies have 
come to the conclusion of increased risk of CRC in diabetic men and women (Wideroff, et al., 
1997) (Hu, et al., 1999) (Weiderpass, Gridley, Nyrén, Ekbom, Persson, & Adami, 1997 ). An 
increased risk of CRC has also been reported in case-control studies by La Vecchia et al and Le 
Marchand et al. (La Vecchia, Negri, Decarli, & Franceschi, 1997 ) (Le Marchand, Wilkens, 
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Kolonel, Hankin, & Lyu, 1997). While La Vecchia reported an increased risk for rectal cancer 
than colon cancer in diabetic patients, LaMarchand found that there was an increased risk of 
developing a left-sided colon cancer whereas rectal cancer was greater in diabetic women than in 
diabetic men. The National Health and Nutrition Survey I (NHANES I) collected extensive 
baseline data via exam and questionnaire from 1971-1975 (Steeland et al, 1995). The subjects 
who were aged 25-74 years at the time were followed through 1987 for mortality and disease 
incidence via death certificate and hospital discharge data. For CRC results showed that for both 
men and women diabetes posed the highest risk but lack of physical non-recreational physical 
activity caused no increase in risk. 
 Following the growing epidemiological evidence of the association of diabetes with 
CRC, McKeown-Eyssen and Giovannucci proposed what came to be popularly known as the 
hyperinsulinemia hypothesis which suggested that high levels of insulin and glucose might be 
risk factors for colorectal carcinogenesis (McKeown-Eyssen, 1994) (Giovannucci E. , 1995). 
This hypothesis grew from trying to explain the link between colorectal cancer, diets high in fat 
and low in vegetables, and obesity and from the observations that insulin promotes the growth of 
colon cells in vitro and colon tumors in vivo. Hyperinsulinemia and hyperglycemia result from 
the dysregulation of the interrelationship between insulin secretion and insulin action, which can 
also eventually lead to the development of type 2 diabetes mellitus. CRC shares these risk factors 
with diabetes mellitus and the hyperinsulinemia hypothesis has been furthered by suggesting that 
because the onset of type 2 diabetes mellitus is characterized by insulin resistance, and in most 
cases, with hyperinsulinemia for compensation there is an increased level of insulin in type 2 
diabetes patients as well which, as a by-product, leads to a complex chain of events promoting 
tumor growth in the colon (Jin, 2008). It also has been suggested that insulin is considered to be 
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a growth factor and insulin receptors are observed in both normal as well as malignant colorectal 
cancer cells; insulin receptors can be bound by insulin-like growth factors, factors which can be 
expressed by colorectal cancers (Chang & Ulrich, 2003 ). 
The influence of diabetes mellitus on the mortality of patients with established colorectal 
cancer has been demonstrated by various authors but with conflicting conclusions. Results from 
a clinical trial by Meyerhardt, et al. were the first to be documented in 2003 when it was found 
that even after adjustment for other predictors of colon cancer, patients with diabetes and high-
risk stage II or stage III colon cancer experienced a significantly higher rate of overall cancer 
mortality and cancer recurrence than non-diabetics (Meyerhardt, et al., 2003 ). Only one other 
prospective study in the United States has investigated this relationship finding a similar positive 
association (Coughlin, Calle, Teras, Petrelli, & Thun, 2004). Retrospective studies have mixed 
conclusions about whether or not pre-existing diabetes affects CRC mortality. A study conducted 
in elderly patients in the Netherlands found that with co-morbidities such as diabetes, patients 
were treated less aggressively and had a worse survival than those with no concomitant disease 
(Lemmens, Janssen-Heijnen, Verheij, Houterman, & Repelaer van Driel, 2005). Other 
retrospective cohort studies have concluded that diabetes did not affect short-term survival, 
cancer specific survival or stage at diagnosis of CRC (Shonka, Anderson, Panwalkar, Reed, 
Steen, & Ganti, 2006) (Jullumstrø, Kollind, Lydersen, & Edna, 2009). Poorly controlled type 2 
diabetes independently predicts early onset of CRC, a more advanced stage at the time of 
presentation and a poorer 5-year survival (Siddiqui, Spechler, Huerta, Dredar, Little, & Cryer, 
2008 ). In a retrospective cohort study of Veterans’ Administration patients it was found that 
diabetes prevalent with CRC did not affect overall survival in their sample which could be due to 
excellent quality of diabetes care prior to and post cancer diagnosis (Chiao, Nambi, & Naik, 
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2010). There exist only two studies that have studied mortality in CRC patients with pre-existing 
diabetes in a large nationally representative sample (Coughlin, Calle, Teras, Petrelli, & Thun, 
2004) (Gross, Guo, McAvay, Allore, Young, & Tinetti, 2006 ). Only the study by Gross et al was 
a retrospective cohort analysis and included incident cases only till the year 1999.  
 
Emergency Surgery for CRC 
 Surgical resection is the only curative treatment of colorectal cancer, performed as an 
open, surgical procedure requiring hospitalization (Redaelli, Cranor, Okano, & Reese, 2003) 
(Mitry, Barthod, Penna, & Nordlinger, 2002).  Potentially fatal complications of colorectal 
cancer include bowel perforation, peritonitis, and obstruction. These complications are 
considered surgical emergencies and are the initial presentation of colorectal cancer in an 
estimated 15% to 30% of patients with colorectal cancer (Diggs, Xu, Diaz, Cooper, & 
Koroukian, 2007). In addition, patients with emergency room presentation of CRC have 
increased 30-day mortality and decreased 5-year survival compared to those scheduled for 
elective surgery (Mitchell, Inglis, Murdoch, & Porter, 2007 ). Other studies have found that 
overall survival at 5 years was 57.5% after elective and 39.1% after emergency surgery for CRC 
(McArdle & Hole, 2004). The Colorectal Cancer Collaborative Group in England examined how 
the outcomes of surgery in elderly patients differ from those in younger patients finding that 
elderly patients who had an increased frequency of comorbid conditions, were more likely to 
present with later-stage disease and undergo emergency surgery, and less likely to have curative 
surgery than younger patients (Colorectal Cancer Collaborative Group, 2000). Their systematic 
review also found that the incidence of postoperative morbidity and mortality increased 
progressively with advancing age. Performance of surgery in the presence of comorbid 
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conditions especially in the elderly can significantly increase mortality (Lemmens, Janssen-
Heijnen, Verheij, Houterman, & Repelaer van Driel, 2005). A study conducted in the 
Netherlands found that among patients with colorectal cancer, comorbidity in general, 
cardiovascular diseases, COPD, venous thromboembolism and diabetes had a negative effect on 
overall survival after surgery. Currently there are no retrospective cohort studies conducted in the 
United States in the extant literature that compare the outcomes of emergency surgery for CRC 
in patients with and without pre-existing diabetes. 
 
Need for the Study 
 Several epidemiological studies have explored the outcomes of CRC in patients with pre-
existing diabetes. Long term mortality in CRC patients with diabetes has been shown to be 
greater than in patients without diabetes by all studies. Although previously conducted 
prospective cohort studies have controlled for bowel obstruction and bowel perforation, (i.e. an 
emergency condition) they have had the disadvantage of not adjusting for other comorbid 
conditions and including only high risk stage I and stage II CRC patients. Retrospective studies 
that have been conducted in the United States largely suffer from small sample sizes or were 
limited to studying a sample that were residents of a single state, and are therefore not 
generalizable to a national population (Polednak A. P., 2006) (Siddiqui, Maddur, Naik, & Cryer, 
2008 ). Some of these studies either had samples whose median age was less than 65 years or did 
not exclusively focus on the elderly, who form two-thirds of all incident CRC cases, as 
previously mentioned. The linked Surveillance, Epidemiology and End-Results (SEER)-
Medicare data are a large population-based source of information for cancer-related 
epidemiologic and health services research. Till the year 1999 there were only 11 SEER areas 
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that participated in the SEER program representing 14% of the US population (Warren, 
Klabunde, Schrag, Bach, & Riley, 2002). With the addition of four more states, the SEER 
program will cover 25% of the US population. Retrospective analysis looking at the outcomes of 
CRC in patients with comorbid conditions such as diabetes using the SEER-Medicare database 
has been conducted by one study which included patients representing only the 11 SEER areas 
(Gross, Guo, McAvay, Allore, Young, & Tinetti, 2006 ). This study also did not adjust for 
emergency presentation of CRC with bowel obstruction or bowel perforation.  
 Outcomes associated with emergency presentation of CRC have been explored by several 
European studies. Only two studies have compared outcomes associated with emergency surgery 
and elective surgery for CRC in the United States (Smothers, Hynan, Fleming, Turnage, 
Simmang, & Anthony, 2003 ) (Kim, Mittal, Konyalian, King, Stamos, & Kumar, 2007). Both 
studies were limited by their extremely small sample sizes (29 and 209 patients) and one study 
failed to comprehensively adjust for variables such as comorbid conditions and stage at 
presentation. Only one retrospective cross-sectional study of a nationally representative sample 
has evaluated the predictors of emergency presentation for CRC. (Diggs, Xu, Diaz, Cooper, & 
Koroukian, 2007) This study used hospitalized in-patient data for just one year and included the 
non-elderly, uninsured patients with third-party payers other than Medicare and did not segregate 
comorbid conditions. No other study exploring the predictors of emergency surgery has been 
conducted in the United States nor has there been a retrospective population based analysis 
comparing the likelihood of emergency CRC surgery in the diabetic elderly versus non-diabetic 
elderly patients. In addition, there are no studies in the US which have looked at the differential 
association of diabetes with stage at diagnosis in a large nationally representative population. 
Studies in other parts of the world show mixed results. 
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 Literature clearly signifies the positive association of diabetes in the incidence of CRC. 
Studies have shown poorer outcomes of patients with comorbid diabetes and CRC compared to 
CRC in non-diabetic patients, especially in the elderly. Emergency presentation with CRC, 
which is an indicator of poor cancer and poor screening practices, is seen in almost a quarter of 
the cases that present with CRC. A statistic from a nationally representative database has shown 
that diabetic elderly women are less likely to undergo screening for CRC. This is also true for 
ethnic minorities and persons of lower socioeconomic status. Poor screening practices, such as 
not using the correct method or not screening in a timely fashion can lead to later detection of 
cancer and increases the chances of presenting as an emergency case. This is directly associated 
with poorer prognosis of the disease and worse outcomes than if the cancer is detected earlier. 
Current screening guidelines do not consider diabetics as a special case for earlier screening or 
more frequent CRC screening. McBean and Yu have reported that elderly diabetic women are 
less likely than elderly non-diabetic women to receive colorectal cancer screening in the 11 
SEER areas studied between 1999-2002. (McBean & X, 2007) If a strong association is found 
between diabetics with later stage at presentation, and emergency presentation with CRC it may 
help strengthen the case for earlier and more frequent screening for CRC in diabetic patients. In 
addition it could also be an indicator of the quality of care provided to diabetics by 
endocrinologists or physicians, awareness of screening guidelines by healthcare providers and 
raise questions at the patient and provider level about the reasons behind such screening 
behavior. Survival analysis of diabetics with CRC compared to non-diabetics conducted in a 
population which is nationally representative and covers almost 28% of the US population will 
also favor the same argument. 
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 The first aim of this study is to investigate the association between diabetes and stage at 
diagnosis of CRC in an elderly population.  The association of other covariates such as coronary 
atherosclerosis, chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), 
age, race, sex, region in the US, patient location, and the frequency of physician office visits with 
stage at CRC diagnosis will also be explored.  
 A second aim is to check the association of diabetes with presenting as an emergency 
condition for CRC surgery in the elderly. This will be followed by an investigation of predictors 
of emergency condition of CRC surgery in the elderly using large nationally representative 
registry data. 
 Finally, the study aims to explore the effect of diabetes on survival of elderly Medicare 
beneficiaries with CRC. This will also explore the association of the covariates including three 
most common comorbid conditions (coronary atherosclerosis, chronic obstructive pulmonary 
disease heart failure), in addition to diabetes, emergency admission, and treatment variables and 
how they affect survival in a CRC patient. 
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DIABETES AND STAGE AT DIAGNOSIS OF COLORECTAL CANCER IN THE MEDICARE 
POPULATION  




Colorectal cancer (CRC) is the third most common form of cancer after prostate/breast 
and lung cancer in the United States. (Gellad, Z.F. 2010; Jemal, A. 2010) In 2011, approximately 
141,210 men and women were expected to be diagnosed and approximately 49,380 are expected 
to succumb to CRC. (American Cancer Society 2011) The incidence of colorectal adenomas, 
which are precursors to the cancer, rises with age and two thirds of all CRC occur in patients 
over the age of 65. (Holt, P.R. 2009) 
Diabetes is one of three most common comorbid conditions seen in elderly patients with 
CRC. (Gross, C.P. 2006)  Several prospective and case-control studies have come to the 
conclusion of increased risk of CRC in diabetic men and women. (Hu, F.B. 1999; Weiderpass, E. 
1997; La Vecchia, C. 1997; Le Marchand, L. 1997)  Diabetes and CRC share several risk factors 
such as diet low in fiber and high in fat, obesity, and hyperinsulinemia. (Giovannucci, E. 2001) 
In addition to the epidemiological evidence of the association of diabetes with CRC, the 
hyperinsulinemia hypothesis has suggested that high levels of insulin and glucose might be risk 
factors for colorectal carcinogenesis. (McKeown-Eyssen,G. 1994; Giovannucci, E. 2007) This 
hypothesis grew from trying to explain the link between colorectal cancer, diets high in fat and 
low in vegetables, obesity and from observations that insulin promotes the growth of colon cells 
in vitro and colon tumors in vivo. Hyperinsulinemia and hyperglycemia result from the 
dysregulation of the interrelationship between insulin secretion and insulin action, which can 
also eventually lead to the development of diabetes. The hyperinsulinemia hypothesis has been 
furthered by suggesting that because the onset of diabetes is characterized by insulin resistance, 
which could lead to hyperinsulinemia, there is an increased level of insulin in diabetes patients as 
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well which, as a by-product, leads to a complex chain of events promoting tumor growth in the 
colon. (Jin, T. 2008) 
Diabetes mellitus also influences mortality of patients with established colorectal cancer. 
Clinical trial results have shown that even after adjustment for other predictors of colon cancer, 
patients with diabetes and high-risk stage II or stage III colon cancer experienced a significantly 
higher rate of overall cancer mortality and cancer recurrence than non-diabetics. (Meyerhardt, 
J.A. 2003) A 16 year prospective study showed that after controlling for high body mass, 
diabetes was significantly associated with fatal colon cancer in men (RR = 1.20, 95% CI 1.06 - 
1.37) and women (RR = 1.24, 95% CI 1.07 - 1.43).(166 Coughlin,S.S. 2004) In addition, poorly 
controlled diabetes independently predicts early onset of CRC, a more advanced stage at the time 
of presentation, and a poorer 5-year survival. (Siddiqui, A.A. 2008)  
Stage at diagnosis for colorectal cancer directly affects mortality and survival. Chances 
for survival are more than 90% for Stage I, 82% for Stage II, 57% for Stage III and drop to 6% 
for Stage IV patients. (Gloeckler Ries, L.A. 2003) Although diabetes has been shown to be 
associated with the incidence and affects the outcomes of CRC, there are no studies in the US 
which have looked at its differential association with stage at diagnosis. Studies in other parts of 
the world have mixed results. A study in 2,762 Taiwanese patients of whom 17 % had diabetes, 
showed no significant difference in stage at diagnosis, although patients without diabetes were 
more frequently diagnosed with stage I (13.7 % vs. 9.0 % in diabetic patients).(Huang, Y.C. 
2011) However, the study included both the elderly as well as younger patients. A Dutch study 
found that patients with diabetes were more often diagnosed with stage II and less often with 
stage I than patients without diabetes, with comparable numbers of stages III and IV. (van de 
Poll-Franse, L.V. 2012) A recent cross-sectional analysis of 539 colorectal cancer patients in 
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Germany concluded that patients with diabetes were probably diagnosed earlier and therefore 
may be at lower risk for advanced stages of colon cancer at diagnosis. (Nagel, J.M. 2012) 
The evidence from prospective and retrospective studies, clinical trials, and 
pathophysiological reports is substantial to claim that a diabetic patient is at increased risk for the 
development of CRC than the average patient. Detection of the cancer at earlier stages greatly 
improves the chances of survival. This, therefore, creates a case for detection of colorectal cancer 
at an earlier stage especially for diabetic patients. 
This study aims to investigate the association between diabetes and stage at diagnosis of 
CRC in an elderly population. This study will be the first to report this relationship in a large 
nationally representative data. The results of the study will add to existing knowledge about the 
association of diabetes and colorectal cancer. The study will also explore the association of other 
covariates such as coronary atherosclerosis, chronic obstructive pulmonary disease (COPD), 
congestive heart failure (CHF), age, race, sex, region in the US, patient location, and the 
frequency of physician office visits with stage at CRC diagnosis which together can inform more 
effective CRC screening interventions. 
 
Methods 
Newly diagnosed CRC patients were identified in the linked Surveillance, Epidemiology, 
and End Results (SEER) – Medicare database from 2003 through 2005. All cases of incident 
cancer reported to the SEER registries are cross-matched with a master file of Medicare 
enrollment. Previous work has demonstrated excellent agreement among data sources in case 
ascertainment. (Potosky, A.L. 1993) Currently, SEER has 17 high quality registries participating 
in the program, representing 12 states, and with the Medicare data it effectively represents the 
elderly population of the entire United States. (Warren, J.L. 2002)  
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Between 2003 and 2005 there were 30,340 cases aged 66 and over with a newly 
diagnosed malignant adenocarcinoma of the colon or rectum. Sixty-six was selected as the cut-
off to ensure that each person would have at least 12 months of Medicare claims prior to the 
diagnosis of CRC. Cases were further included if  they had 1) only one primary cancer, 2) were 
eligible for both Part A and B benefits for at least 12 months prior to cancer diagnosis, and 3) did 
not die in the same month as their cancer diagnosis. Cases with unknown race were eliminated 
(N= 38). Cases were further deleted if the source of information was from autopsy or death 
certificate only (N= 9). Finally, cases were deleted if their cancer stage was zero or unknown 
(N=5,059). 
SEER reports disease stage using the third edition of the American Joint Committee on 
Cancer (AJCC) definition for the 2003 cases and AJCC Cancer Staging Manual 6th edition 
definition for cases diagnoses in 2004 and 2005. Comprehensive stage categories were collapsed 
into stages I, II, III and IV. At stage II and over the cancer may expand to other organs and could 
also include distant metastases and lymph node involvement, which are strong predictors of 
outcome following surgical resection of the cancer. (Gloeckler Ries, L.A. 2003) In addition, 
chemotherapy is recommended for treatment only at stage II, III and IV. Therefore, a 
dichotomous variable “stage” was created by retaining stage I patients as “early stage” and 
collapsing stages II, III and IV into a second category, “late stage”.  
Inpatient, outpatient, and physician claims for diabetes for each patient during a period of 
12 months before diagnosis of CRC were searched. To maximize specificity, a patient was 
identified as diabetic if he or she had at least one inpatient claim or two outpatient claims for 
diabetes. (Hebert, P.L. 1999) Since the majority of the patients diagnosed with CRC are over the 
age of 65 years they tend to have a greater number of comorbid conditions than younger patients. 
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Multimorbidity has a strong impact on the screening, treatment, and survival of patients. 
(Yancik, R. 1998; Extermann, M. 2000) Therefore, the association of diabetes with stage at 
diagnosis of CRC must be conducted using some of the most common chronic comorbid 
conditions seen in these patients as covariates. Comorbid conditions were searched using similar 
criteria and the three most common chronic conditions i.e. CHF, coronary atherosclerosis, and 
COPD were selected to be included as covariates.  
Age was categorized as 66-69 years; 70-74 years; 75-79 years; 80-84 years; and 85 years 
and over. Race was categorized as white, black, and other. SEER areas to which the patients 
belonged were categorized as west, mid-west, south, and east depending on the region in the US. 
Location of the tumor was categorized as proximal (cecum to splenic flexure) and distal 
(descending colon to rectum). The categorization was based on the ease of cancer detection 
based on the method used for screening or diagnosis. Proximal cancers are identified primarily 
through the use of colonoscopy, unlike a sigmoidoscopy which would be unable to reach these 
areas. The number of physician office visits 12 months prior to cancer diagnosis was identified 
and the continuous variable was transformed into quintiles of office visits with the first quintile 
representing the highest number of office visits. 
Diabetic patients were matched to non-diabetic patients using a propensity score analysis 
in order to control for confounding by factors related to treatment selection. (Rubin, D.B. 1997) 
Each Diabetic was matched with two non-diabetics on five characteristics, namely, age, sex, 
race, location of the tumor and the SEER region that the patient belonged to. Patients for whom 
there was no match were excluded. The final cohort consisted of 16,398 patients.  
Patients with cancer detected at an early stage were compared to those detected at late 
stage and those with and without diabetes were compared, using Pearson chi-square tests for 
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comparisons of proportions. Logistic regression was carried out to explore the association 
between diabetes status and early or late stage of CRC diagnosis using the Enter method with 
demographic characteristics, patient location, and region as covariates. A separate logistic 
regression was run adding number of physician office visits as a covariate. The multivariable-
adjusted models were constructed using a logit link and a binomial distribution. All statistical 
analyses were conducted using IBM SPSS 20. 
 
Results 
The mean age of the study cohort was 76.8 years (range 66 to 114) and there were 52.0% 
females. Patients were evenly distributed between all stages with 24.8% diagnosed at stage I, 
29.9% at stage II, 26.8% at stage III, and 18.6% at stage IV. Tumors were equally divided as 
well, with 50.3% located in the proximal area of the colon. There were 5,466 diabetics in the 
cohort. 
Chi square analyses for stage at diagnosis (Table 1) showed significant differences 
between age groups. Patients over the age of 80 were more likely to be diagnosed at later stages 
than stage I. Significant relationships were seen between stage at diagnosis with presence of 
diabetes and coronary atherosclerosis. Proximal tumors were more likely to be diagnosed at later 
stage than distal tumors. Frequency of office visits was also related to stage at diagnosis; patients 
with fewer office visits had a greater chance of being diagnosed at late stage. Chi square analyses 
for presence of diabetes (Table 2) showed no differences in age, sex and race. There were more 
diabetics than non-diabetics that had coronary atherosclerosis (35.5% vs 17.7%), COPD (13.8% 
vs 10.4%) and CHF (19.5% vs 8.0%). Diabetics also had a higher frequency of office visits than 
non-diabetics.  
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Two separate logistic regression models are presented. The first model (Table 3) shows 
that diabetes has a significant association with stage at presentation of CRC (OR 0.92; 95% CI 
0.85-1.00). Presence of coronary atherosclerosis has lower odds of presenting with later stage of 
the cancer (OR 0.85; 95% CI 0.78-0.93). Proximal tumors had 35% greater odds (OR 1.35; 95% 
CI 1.26-1.46) of being diagnosed at later stages than tumors located distally. On adding quintile 
of office visits to the second model (Table 4) diabetes showed no association with stage at 
diagnosis of CRC. Elderly patients over the age of 80 were associated with late stage at 
diagnosis. Proximal tumor location continued to remain significantly associated with later stage 
at diagnosis (OR 1.40; 95% CI 1.30-1.51). The number of office visits was significantly 
associated with stage at diagnosis with decreasing frequency of office visits associated with later 
stage at diagnosis. 
 
Discussion 
This study aimed to check the association of diabetes with stage at diagnosis of CRC in a 
large nationally representative sample of elderly Medicare beneficiaries. Previous studies in the 
US and other countries have tested this association in smaller samples with conflicting results. In 
this study, diabetes did not show a significant association with stage at diagnosis for CRC. 
However, diabetic CRC patients tend to have poorer outcomes than non-diabetic patients, and 
therefore it can be argued that the cancer should be detected at an earlier stage than non-diabetics 
due to the survival benefit provided at being treated at earlier stages. In addition, if left 
uncontrolled, diabetes outcomes in CRC patients are even worse than those with controlled 
diabetes. (Siddiqui, A.A. 2008)  
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This study also showed that diabetics visited physicians more frequently than non-
diabetics and were more likely to have comorbid conditions such as coronary atherosclerosis, 
COPD and CHF. This would predispose them to greater recommendations for screening for 
various diseases including for CRC and one would therefore expect them to be diagnosed at an 
earlier stage than non-diabetics. However, as seen in the regression model, after adjusting for the 
number of physician office visits this was not so. A review of barriers and facilitators to 
screening for CRC in patients over the age of 65 has reported that although Medicare's coverage 
of screening colonoscopy was consistently reported as a facilitator, the most cited barrier related 
to healthcare providers was lack of screening recommendation by a physician. (Guessous,I. 
2010) Compared to average risk patients, i.e. patients over the age of 50 with no chronic diseases 
or history of cancer, diabetics are at an increased-risk for colorectal cancer. A recent study that 
examined screening patterns in individuals with varying risk for CRC found that compared to 
average risk patients, diabetics were less likely to be recommended by physicians for CRC 
screening and were also less likely to be adherent to a recommendation if one was made. (Felsen, 
C.B. 2011)  
It is important to note that patients over the age of 80 are more likely to be diagnosed at a 
later stage than younger patients. This could be due to some guidelines cautioning against use of 
invasive methods for screening for patients over the age of 75 due to possible adverse effects of 
screening. (Qaseem, A. 2012)  All guidelines specifically do not recommend using any invasive 
method for screening patients over the age of 85. 
 The results in this study show that tumors detected within the proximal region in the 
colon are found to have progressed much more than the ones located in the distal region at the 
time of detection. Distal tumors are easier to detect with less invasive procedures such as 
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sigmoidoscopy which cannot look at the large intestine in its entirety and is recommended more 
frequently than colonoscopies. Sigmoidoscopes cannot reach the proximal areas of the large 
intestine leading to tumors in those areas to go undetected. (Schoen, R.E. 2012) In addition, 
proximal tumor location even after controlling for stage has also been significantly associated 
with poorer mortality and survival as compared to distally located colon cancers. (Wray, C.M. 
2009) This study points to a greater need for further investigation in the differential prevalence 
of colorectal tumor location in the elderly. Future studies should also investigate use of screening 
methods and their association with tumor location in the colorectal region and how it affects 
outcomes such as survival and mortality. 
 Although this study has several strengths including stringent inclusion and exclusion 
criteria, a large nationally representative sample, and registry level data, it must be seen in light 
of its limitations. We used previously employed algorithms to identify diabetic patients, 
however, we were unable to identify the duration of diabetes as well as clinical values such as 
HbA1C which may have significantly affected the stage at which patients were diagnosed with 
CRC. Siddiqui et al have reported that uncontrolled diabetes and therefore increased HbA1C 
levels leads to diagnosis of CRC at later stages than diabetes that is under control. (Siddiqui, 
A.A. 2008) Future studies in the elderly must take into consideration clinical values and duration 
of diabetes. Timely screening plays a crucial role in detecting the cancer at earlier stages and the 
data did not allow us to check for frequency of screening. This is especially true for 
sigmoidoscopy and colonoscopy procedures which are recommended to be performed at five 
year and ten year intervals, respectively. In addition, SEER–Medicare data do not include other 
important measures of health status, such as body mass index, diet, functional disabilities or 
geriatric syndromes. 
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 In conclusion, this study shows that the association between diabetes and stage at 
diagnosis of colorectal cancer in those 65 years and older, although not statistically significant, 
must be further explored. Tumor location in diabetics must be studied further with a focus on 
detecting proximal tumors at earlier stages. Dialogue between the physician and diabetic patient 
should be encouraged to discuss screening for CRC. Diabetic patients should be screened for the 
cancer either more frequently or begin at an age earlier than the average risk patient in order to 
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Table 1: Characteristics of patients by Stage at Diagnosis of CRC 
Patient Characteristic Stage at Diagnosis p 
  Early   Late     
 
N % N % 
 Age Group 
    
0.004 
66-69 730 18.0% 2,085 16.9% 
 70-74 962 23.7% 2,823 22.9% 
 75-79 1,070 26.4% 3,124 25.3% 
 80-84 776 19.1% 2,452 19.9% 
 85 and over 521 12.8% 1,855 15.0% 
 Sex 
    
0.295 
Male 1,977 48.7% 5,893 47.8% 
 Female 2,082 51.3% 6,446 52.2% 
 Race 
    
0.379 
White 3,246 80.0% 9,888 80.1% 
 Black 416 10.2% 1,322 10.7% 
 Other 397 9.8% 1,129 9.1% 
 Diabetes 
 
   0.003 
No 2,629 64.8% 8,303 67.3% 
 Yes 1,430 35.2% 4,036 32.7% 
 Atherosclerosis 
    
0.000 
No 3,007 74.1% 9,509 77.1% 
 Yes 1,052 25.9% 2,830 22.9% 
 COPD 
    
0.055 
No 3,558 87.7% 10,953 88.8% 
 Yes 501 12.3% 1,386 11.2% 
 CHF 
    
0.183 
No 3,553 87.5% 10,897 80.5% 
 Yes 506 12.5% 1,442 11.7% 
 Region 
    
0.736 
West 1,525 37.6% 4,677 37.9% 
 Midwest 624 15.4% 1,881 15.2% 
 South 798 19.7% 2,336 18.9% 
 East 1,112 27.4% 3,445 27.9% 
 Tumor Site 
    
0.000 
Distal Tumor 2,249 55.4% 5,895 47.8% 
 Proximal Tumor 1,810 44.6% 6,444 52.2% 
 Quintile Office Visits 
    
0.000 
First 1,025 25.3% 2,556 20.7% 
 Second 919 22.6% 2,573 20.9% 
 Third 833 20.5% 2,430 19.7% 
 Fourth 749 18.5% 2,316 18.8% 
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Table 1: Characteristics of patients by Stage at Diagnosis of CRC 
Patient Characteristic Stage at Diagnosis p 
  Early   Late     
Patient Location 
    
0.141 
Big Metro 2,225 54.8% 6,993 56.7% 
 Metro 1,143 28.2% 3,390 27.5%  
Urban 248 6.1% 708 5.7% 
 Less Urban 369 9.1% 994 8.1% 
 Rural 74 1.8% 254 2.1% 
 TOTAL 4,059   12,399     
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Table 2: Characteristics of patients by Diabetes Status 
  Patient Characteristic Presence of Diabetes p 
 
No Yes 
   N % N %   
Age Group 
    
0.150 
66-69 1,919 17.6% 896 16.4% 
 70-74 2,528 23.1% 1,257 23.0% 
 75-79 2,738 25.0% 1,456 26.6% 
 80-84 2,165 19.8% 1,063 19.4% 
 85 and over 1,582 14.5% 794 14.5% 
 Sex     0.683 
Male 5,259 48.1% 2,611 47.8% 
 Female 5,673 51.9% 2,855 52.2% 
 Race     0.320 
White 8,788 80.4% 4,346 79.5% 
 Black 1,132 10.4% 606 11.1% 
 Other 1,012 9.3% 514 9.4% 
 Stage     0.003 
Early 2,629 24.0% 1,430 26.2% 
 Late 8,303 76.0% 4,036 73.8% 
 Coronary Athero     0.000 
No 8,992 82.3% 3,524 64.5% 
 Yes 1,940 17.7% 1,942 35.5% 
 COPD     0.000 
No 9,797 89.6% 4,714 86.2% 
 Yes 1,135 10.4% 752 13.8% 
 CHF     0.000 
No 10,052 92.0% 4,398 80.5% 
 Yes 880 8.0% 1,068 19.5% 
 Region     0.440 
West 4,138 37.9% 2,064 37.8% 
 Midwest 1,637 15.0% 868 15.9% 
 South 2,111 19.3% 1,023 18.7% 
 East 3,046 27.9% 1,511 27.6% 
 Tumor Site     0.799 
Distal Tumor 5,437 49.7% 2,707 49.5% 
 Proximal Tumor 5,495 50.3% 2,759 50.5% 
 Quintile Office Visits     0.000 
First 1,714 15.7% 1,867 34.2% 
 Second 2,027 18.5% 1,465 26.8% 
 Third 2,133 19.5% 1,130 20.7% 
 Fourth 2,283 20.9% 782 14.3% 
 Fifth 2,775 25.4% 222 4.1% 
  
Continued 
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Table 2: Characteristics of patients by Diabetes Status 
  Patient Characteristic Presence of Diabetes p 
 
No Yes 
   N % N %   
Patient Location     0.814 
Big Metro 6,143 56.2% 3,075 56.3% 
 Metro 3,001 27.5% 1,532 28.0% 
 Urban 641 5.9% 315 5.8% 
 Less Urban 923 8.4% 440 8.0% 
 Rural 224 2.0% 104 1.9% 
 TOTAL 10,932 100.0% 54,66 100%   
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Table 3: Association of diabetes with stage at diagnosis of Colorectal Cancer 
Patient Characteristic p 
  
Odds 
95% C.I.for Odds 
Sig Lower Upper 
Comorbidities 
Diabetes .039 *** 0.92 0.85 1.00 
 
Coronary Athero .000 *** 0.85 0.78 0.93 
 
COPD .200  0.93 0.83 1.04 
 
CHF .957  1.00 0.89 1.12 
Age Group 
66-69 .019 Referent    
 
70-74 .658  1.03 0.92 1.15 
 
75-79 .905  1.01 0.90 1.12 
 
80-84 .158  1.09 0.97 1.23 
 
85 and over .004 *** 1.21 1.06 1.39 
Sex 
Female .518  0.98 0.91 1.05 
Race 
White .395 Referent    
 
Black .516  1.04 0.92 1.17 
 
Other .254  0.93 0.82 1.06 
Tumor Location 
Proximal .000 *** 1.35 1.26 1.46 
Region in the US 
WEST .941 Referent    
 
MIDWEST .653  0.97 0.87 1.09 
 
SOUTH .561  0.97 0.87 1.08 
 
EAST .755  0.99 0.90 1.08 
Patient Location 
Big Metro .153 Referent    
 
Metro .148  0.94 0.86 1.02 
 
Urban .264  0.92 0.78 1.07 
 
Less Urban .040  0.86 0.75 0.99 
 
Rural .524  1.09 0.83 1.43 
  Constant .000   2.64     
Coronary Athero = Coronary Atherosclerosis; COPD = Chronic Obstructive Pulmonary Disorder; CHF = 
Congestive Heart Failure 
Referent group for Diabetes, Coronary Atherosclerosis, COPD and CHF are No Diabetes, No Coronary 
Atherosclerosis, No COPD and No CHF respectively 
Referent group for female is male 
Referent group for proximal tumor location is distal tumor location 
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Table 4: Association of diabetes with stage at diagnosis of Colorectal Cancer 
Patient Characteristic p 
  
Odds 
95% C.I.for Odds 
Sig Lower Upper 
Comorbidities 
Diabetes .309  1.04 0.96 1.13 
 
Coronary Athero .370  0.96 0.87 1.05 
 
COPD .750  1.02 0.91 1.14 
 
CHF .214  1.08 0.96 1.22 
Age Group 
66-69 .000 Referent    
 
70-74 .357  1.05 0.94 1.18 
 
75-79 .258  1.07 0.95 1.19 
 
80-84 .009 *** 1.18 1.04 1.33 
 
85 and over .000 *** 1.32 1.15 1.50 
Sex 
Female .483  1.03 0.95 1.11 
Race 
White .342 Referent    
 
Black .988  1.00 0.89 1.13 
 
Other .145  0.91 0.80 1.03 
Tumor Location 
Proximal .000 *** 1.40 1.30 1.51 
Region in the US 
WEST .820 Referent    
 
MIDWEST .503  0.96 0.86 1.08 
 
SOUTH .373  0.95 0.85 1.06 
 
EAST .730  0.98 0.90 1.08 
Patient Location 
Big Metro .081 Referent    
 
Metro .090  0.93 0.86 1.01 
 
Urban .192  0.90 0.77 1.05 
 
Less Urban .020  0.85 0.74 0.97 
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Table 4: Association of diabetes with stage at diagnosis of Colorectal Cancer 
Patient Characteristic p 
  
Odds 
95% C.I.for Odds 
Sig Lower Upper 
Quintile of Office 
Visits 
First Quintile .000 Referent    
 
Second .007 *** 1.16 1.04 1.29 
 
Third .000 *** 1.25 1.12 1.40 
 
Fourth .000 *** 1.37 1.21 1.54 
 
Fifth .000 *** 2.13 1.86 2.44 
  Constant .000   1.671     
Coronary Athero = Coronary Atherosclerosis; COPD = Chronic Obstructive Pulmonary Disorder; CHF = 
Congestive Heart Failure 
Referent group for Diabetes, Coronary Atherosclerosis, COPD and CHF are No Diabetes, No Coronary 
Atherosclerosis, No COPD and No CHF respectively 
Referent group for female is male 
Referent group for proximal tumor location is distal tumor location 
First quintile in Office Visits represents highest number of office visits and fifth represents the lowest 
  




ASSOCIATION OF DIABETES AND PREDICTORS OF EMERGENCY CONDITION FOR COLORECTAL 
CANCER SURGERY IN THE MEDICARE POPULATION  




Colorectal cancer (CRC) is ranked third in incidence and mortality of all cancers in both 
men and women. (American Cancer Society, 2011; Gellad & Provenzale, 2010; Jemal, Siegel, 
Xu, & Ward, 2010) In 2011 approximately 141,210 men and women were expected to be 
diagnosed and approximately 49,380 are expected to succumb to CRC. (American Cancer 
Society, 2011) Screening for CRC can identify polyps or abnormal growths before they turn 
cancerous. Disparities in screening, treatment, and survival persist even with incidence and 
mortality from CRC decreasing significantly due to increasing screening rates. (Gellad & 
Provenzale, 2010) (Hao, Jemal, Zhang, & Ward, 2009; Hoff & Dominitz, 2010; Meissner, Breen, 
Klabunde, & Vernon, 2006) 
The incidence of CRC is uncommon under the age of 50 years where it is predominantly 
in tumors induced by heredity and with a family history. However, between the ages of 50 and 
85 years the incidence increases exponentially, with two-thirds of all cancers occurring in 
patients over the age of 65. (Everhart & Ruhl, 2009; Ries et al., 2007; Rim, Seeff, Ahmed, King, 
& Coughlin, 2009)  
Comorbidity, or illnesses other than the primary illness under treatment, is more common 
in the elderly. (Shack, Rachet, Williams, Northover, & Coleman, 2010) Older individuals also 
often present with chronic conditions that complicate the diagnostic and clinical management of 
CRC which leads to poorer prognosis and outcomes of the cancer. (Satariano & Silliman, 2003; 
Yancik et al., 1998) In their review of population-based studies including CRC patients 65 years 
and older, Faivre and colleagues reported that comorbidity was shown to be an independent 
prognostic factor. (Faivre, Lemmens, Quipourt, & Bouvier, 2007). The study added that 
Neel Shah  Dissertation 
47 
 
comorbidities such as previous malignancy, cardiovascular diseases, chronic obstructive 
pulmonary disease (COPD), hypertension and diabetes decreased 5-year survival compared to 
patients with CRC with no comorbidity. The three most common comorbid conditions seen in 
elderly patients with CRC are congestive heart failure, chronic obstructive pulmonary disease 
and diabetes mellitus. (Gross et al., 2006) There is a lack of studies exploring the association of 
chronic comorbid conditions with the diagnosis of CRC.   
 Of all comorbid conditions, the association of diabetes with CRC has been studied most 
extensively and has been established with prospective, case-control and retrospective studies 
providing overwhelming evidence. (Elwing, Gao, Davidson, & Early, 2006; Hu et al., 1999; Hu 
et al., 1999; Limburg et al., 2005; Limburg et al., 2006; Vinikoor et al., 2009; Will, Galuska, 
Vinicor, & Calle, 1998)  Unlike with other diseases, in addition to the epidemiological evidence, 
pathophysiological evidence has also contributed in understanding the link between diabetes and 
CRC. (Giovannucci, 2001; Jin, 2008; McKeown-Eyssen, 1994) Diabetes also affects the 
outcomes of CRC as reported by several investigators. Reports from around the world have 
concluded that diabetic CRC patients have worse outcomes than non-diabetic patients which may 
either be a results of less aggressive treatment of the cancer or poorly controlled diabetes. 
(Coughlin, Calle, Teras, Petrelli, & Thun, 2004; Gross et al., 2006; Lemmens et al., 2005; 
Meyerhardt et al., 2003; Siddiqui et al., 2008) Surgical resection is the only curative treatment of 
colorectal cancer, performed as an open, surgical procedure requiring hospitalization. (Mitry, 
Barthod, Penna, & Nordlinger, 2002; Redaelli, Cranor, Okano, & Reese, 2003)  Emergency 
presentation with CRC, which is an indicator of poor prognosis, and poor screening practices, is 
seen in almost a quarter of the cases that present with CRC. (Kim et al., 2007; Polednak, 2000; 
Smothers et al., 2003) A nationally representative database has shown that diabetic elderly 
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women are less likely to undergo screening for CRC. (Limburg et al., 2005) This is also true for 
ethnic minorities and persons of lower socioeconomic status. (Hood et al., 2010; Rich, Kuyateh, 
Dwyer, Groves, & Steinberger, 2011) Poor screening practices, such as not using the correct 
method or not screening in a timely fashion can lead to later detection of cancer and increases the 
chances of presenting as an emergency case. This is directly associated with poorer prognosis of 
the disease and worse outcomes than if the cancer is detected earlier.  
Potentially fatal complications of colorectal cancer include bowel perforation, peritonitis, 
and obstruction. These complications are considered surgical emergencies and are the initial 
presentation of colorectal cancer in an estimated 15% to 30% of patients with colorectal cancer. 
(Diggs, Xu, Diaz, Cooper, & Koroukian, 2007)In addition, patients with emergency room 
presentation of CRC have increased 30-day mortality and decreased 5-year survival compared to 
those scheduled for elective surgery. (Mitchell, Inglis, Murdoch, & Porter, 2007)  
Predictors of presenting as an emergency have been examined by Polednak who used the 
Connecticut tumor registry to estimate the frequency and characteristics of first inpatient hospital 
admission through an emergency department (ED) among more than 11,000 patients. (Polednak, 
2000). He found that age greater than 75 years, black race, and proximal cancer were significant 
predictors of admission through the ED. A study by Diggs and colleagues used hospital 
discharge data to examine the association of demographic characteristics, insurance status and 
number of comorbidities with emergency condition for CRC resection surgery. They found that 
older age, being male, black and being uninsured increased the likelihood of presenting 
emergently. (Diggs et al., 2007) However, the study by Polednak did not examine any comorbid 
conditions such as diabetes and was limited to patients in Connecticut, and Diggs’ study is 
limited by the fact that they used discharge data not incident data, used elderly as well as 
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younger patients, was lacking in information on stage of cancer, and had no information on 
specific comorbid conditions. No other study in the US has attempted to study the predictors of 
emergency condition for CRC surgery. 
As evidence shows diabetic patients are at an increased risk for the development of CRC 
and are predisposed to worse outcomes than a non-diabetic CRC patient. A diabetic patient 
presenting as an emergency condition for CRC surgery could compound the prognosis, with a 
potential for poorer chances of survival. Therefore, it is imperative to check the association of 
diabetes and other covariates with presenting emergently for CRC surgery.   This study is the 
first to comprehensively study the predictors of emergency condition for CRC resection surgery 
in newly diagnosed CRC patients over 65 years of age. This study is also the first to report the 
association of diabetes and other frequently seen comorbid conditions in CRC patients over 65 
years of age with emergency condition for surgical resection. The aim of the study is to check the 
association of diabetes with presenting as an emergency condition for CRC surgery in those over 
65 years of age. A second aim is to indentify predictors of emergency condition of CRC surgery 




 The study was a retrospective cross sectional analysis of data from the Surveillance, 
Epidemiology and End Results-Medicare (SEER-Medicare) files for the years 2003 to 2005. The 
SEER-Medicare data reflect the linkage of two large population-based sources of data that 
provide detailed information about Medicare beneficiaries with cancer. The data come from the  
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SEER program of cancer registries that collect clinical, demographic and cause of death 
information for persons with cancer and the Medicare claims for covered health care services 
from the time of a person's Medicare eligibility until death. The linkage of these two data sources 
results in a unique population-based source of information that can be used for an array of 
epidemiological and health services research. Previous work has demonstrated excellent 
agreement among data sources in case ascertainment. (Potosky, Riley, Lubitz, Mentnech, & 
Kessler, 1993) Currently, SEER has 17 high quality registries participating in the program, 
representing 12 states, and with the Medicare data it effectively represents the elderly population 
of the entire United States. (Warren, Klabunde, Schrag, Bach, & Riley, 2002)  
Cohort 
 Between 2003 and 2005 there were 30,340 cases aged 66 and over with a newly 
diagnosed malignant adenocarcinoma of the colon or rectum. Sixty-six was selected as the cut-
off to ensure that each person would have at least 12 months of Medicare claims prior to the 
diagnosis of CRC. Cases were further included if  they had 1) only one primary cancer, 2) were 
eligible for both Part A and B benefits for at least 12 months prior to cancer diagnosis, and 3) did 
not die in the same month as their cancer diagnosis. Cases with unknown race were eliminated 
(N= 38). Cases were further deleted if the source of information was from autopsy or death 
certificate only (N= 9). Finally, cases were deleted if their cancer stage was zero or unknown 
(N=5,059). Cases were also excluded if they did not undergo any type of CRC resection surgery 
(N = 4,152).  
The next step was to identify patients who underwent CRC resection procedures in the 
colon and rectum. These patients were identified using the International Classification of 
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Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) procedure codes for colon resection  
(codes 45.7x and 45.8), rectal resection (codes 48.4x, 48.5, 48.6x), and other operations on the 
intestine including colostomy and ileostomy (codes 46.1-2). (Diggs et al., 2007; Etzioni, Beart, 
Madoff, & Ault, 2009; Hayanga et al., 2010) Patients were identified as being an emergency case 
for CRC surgery if they also had diagnosis codes of bowel perforation, peritonitis, or obstruction. 
The ICD-9-CM diagnosis codes used to determine which patients met these criteria included 
other specified intestinal obstruction (code 560.8), unspecified intestinal obstruction (code 
560.9), peritonitis in infectious diseases (code 567.0), other suppurative peritonitis (code 567.2), 
other specified peritonitis (code 567.8), unspecified peritonitis (code 567.9), and perforation of 
the intestine (code 569.83). The final cohort for this study consisted of 21,082 patients. 
Construction of Variables 
Inpatient, outpatient, and physician claims for diabetes for each patient during a period of 
12 months before diagnosis of CRC were searched. To maximize specificity, a patient was 
identified as diabetic if he or she had at least one inpatient claim or two outpatient claims for 
diabetes. (Hebert et al., 1999) Since majority of the patients diagnosed with CRC are over the 
age of 65 years they tend to have a greater number of comorbid conditions than younger patients. 
Multimorbidity has a strong impact on the screening, treatment, and survival of patients. 
(Extermann, 2000; Yancik et al., 1998) Therefore, the association of diabetes with emergency 
surgery for CRC must be conducted using some of the most common chronic comorbid 
conditions seen in these patients as covariates. Comorbid conditions were searched using similar 
criteria and the three most common chronic conditions i.e. congestive heart failure (CHF), 
coronary atherosclerosis, and COPD were selected to be included as covariates.  
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SEER reports disease stage using the third edition of the American Joint Committee on 
Cancer (AJCC) definition for the 2003 cases and AJCC Cancer Staging Manual 6th edition 
definition for cases diagnoses in 2004 and 2005. Comprehensive stage categories were collapsed 
into stages I, II, III and IV. Stage at diagnosis for colorectal cancer directly affects mortality and 
survival. Chances for survival are more than 90% for Stage I, 82% for Stage II, 57% for Stage III 
and drop to 6% for Stage IV patients.{{189 Gloeckler Ries,L.A. 2003}}Due to these differential 
survival rates between the stages, patients were categorized as being “Early Stage” (Stage I and 
II) or “Late Stage” (Stages III and IV) patients. 
Age was categorized as 66-69 years, 70-74 years, 75-79 years, 80-84 years, and 85 years 
and over. Race was categorized as white, black, and other. SEER areas to which the patients 
belonged were categorized as west, mid-west, south, and east depending on the region in the US. 
Location of the tumor was categorized as proximal (cecum to splenic flexure) and distal 
(descending colon to rectum). The categorization was based on the ease of cancer detection 
based on the method used for screening or diagnosis. Proximal cancers are identified primarily 
through the use of colonoscopy, unlike a sigmoidoscopy which would be unable to reach these 
areas. The number of physician office visits 12 months prior to cancer diagnosis was identified 
and the continuous variable was transformed into quintiles of office visits with the first quintile 
representing the highest number of office visits. 
Analyses 
Patients undergoing emergency versus elective surgery for CRC were initially compared 
using descriptive statistics against the independent variables using Pearson chi-square tests for 
comparison of proportions. Similarly patients with and without diabetes were also compared 
using the bivariate statistic. 
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The association of diabetes with emergency surgery for CRC was analyzed by employing 
multivariate logistic regression. After check the goodness-of-fit using the Hosmer-Lemeshow 
test statistic, the final model using the Enter method was analyzed. The predictors of emergency 
surgery for colorectal cancer were tested in the same model. The multivariable-adjusted models 
were constructed using a logit link and a binomial distribution. All statistical analyses were 
conducted using IBM SPSS 20. 
Results 
 In a sample of 21,082 patients, the mean age was 77.4 years (range 66 to 106 years). 
There were 56.5% female patients and the sample was largely white (85.3%). There were 22.2% 
diabetic patients, 22.0% of the sample had coronary atherosclerosis, and the proportion of 
patients that had COPD and CHF were 10.8% and 10.6%, respectively. The sample had a 
proportion of 23.1% patients that were diagnosed at Stage I, 33.8% at stage II, 29.4% at stage III 
and 13.7% at stage IV. Tumor location was evenly distributed among the patients with 54.1% 
patients having a proximal tumor. The number of patients that were classified as having an 
emergency condition for CRC surgery was 2,242 or 10.4% of the sample. 
 The bivariate analysis for emergency versus non-emergency patients showed that older 
patients were more likely to be a candidate for emergency surgery for CRC (Table 1). This was 
especially seen in patients over the age of 80 years. Patients classified as emergency candidates 
were more likely to be diagnosed at later stages than earlier stages and there was a significantly 
greater likelihood of a patient having a distal tumor than a proximal tumor. The results also 
showed that patients with lower frequency of office visits were more likely to be classified as an 
emergency rather than non-emergency case. There was also a significant difference between 
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diabetics and non-diabetics in their distribution between emergency and non-emergency 
condition for CRC surgery.  
 The distribution of patients between diabetics and non-diabetics by age showed that with 
increasing age in the elderly, the proportion of diabetics increased and peaked between the age 
range 75-79 years and then decreased thereafter (Table 2). There were more diabetic women in 
the sample than men, and there were more diabetic patients of black and other races than white 
patients. Diabetic patients represented the most frequently visited category in terms of quintiles 
of physician office visits, and the eastern region of the US had a greater proportion of diabetics 
than the rest of the country.  
 Logistic regression results (Table 3) indicated that although the odds of a diabetic patient 
being an emergency patient were lower than a non-diabetic, this was not statistically significant 
(OR 0.89; 95% CI 0.79-1.01). Coronary atherosclerosis patients had lower odds of being 
classified as emergency (OR 0.82; 95% CI 0.72-0.93) whereas those with COPD had increased 
odds (OR 1.28; 95% CI 1.11-1.49). Patients with late stage at diagnosis had a 75% greater 
chance of being emergency patients than stage I patients (OR 1.75; 95% CI 1.60-1.91).  Proximal 
tumor location lent itself to being negatively associated with being classified as an emergency 
case for CRC surgery. Compared to whites, blacks were more prone to being emergency cases 
(OR 1.27; 95% CI 1.08-1.49). The regression also showed that compared to the highest quintile 
of office visits, patients belonging to the lowest quintile had greater odds of being an emergency 
patient (OR 1.48; 95% CI 1.26-1.74).  
 
 




This study is the first to report the association of diabetes with emergency surgery for 
CRC, and explore the predictors of emergency colorectal cancer surgery in a large nationally 
representative sample. The study showed that although the odds of being an emergency patient 
for CRC surgery were lower for diabetic patients, this association was not significant. However, 
this result must be interpreted in light of the fact that diabetic patients belonged to the highest 
quintile in terms of physician office visits. Previous reports of a Medicare population have 
mentioned that  having any physician office visit, increased number of office visits, and visits 
with primary care physicians are associated with increased CRC test use. (Schenck et al., 2011)  
Klabunde and colleagues have reported that having a chronic condition such as diabetes is a 
predictor of receiving a physician recommendation for CRC screening. (Klabunde, Schenck, & 
Davis, 2006)  Increased number of physician office visits increases the chances of being 
recommended for a screening test; and clinician recommendation for a screening test has been 
proven to be a strong predictor in the elderly as well as young patients to adhere to screening 
practices for CRC. (Felsen, Piasecki, Ferrante, Ohman-Strickland, & Crabtree, 2011; Gilbert & 
Kanarek, 2005) 
This study also showed that compared to Whites, Black patients were more likely to be 
classified as an emergency condition for CRC surgery. It has been reported that Blacks, 
Hispanics, and American Indians/Alaska Natives were less likely to report receiving 
a recommendation for sigmoidoscopy compared to Whites. (Coughlin & Thompson, 2005) 
Whites are also more likely than Blacks to report ever receiving a provider recommendation for a 
colonoscopy. Although the proportion of patients receiving recommendations for 
colonoscopy/sigmoidoscopy increased over time, the gap between races remained unchanged, 
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even after controlling for insurance status. (Rich et al., 2011) A study by Hood and colleagues 
has reported that although over 80% of their sample of 439 blacks was covered by insurance, less 
than 50% reported receiving a recommendation to screen for CRC. (Hood et al., 2010) This calls 
for immediate intervention and strategies for improving physician recommendation in this 
subgroup of the population.  
This study also showed that the odds of being an emergency case for CRC surgery were 
higher for patients over the age of 80 years. However, this may be due to several guidelines 
cautioning against use of invasive methods for screening of patients over the age of 75 because 
of possible adverse effects of screening. Thus it is possible that the cancer does not get detected 
in early stages in this age group. (Qaseem et al., 2012)  All the guidelines specifically do not 
recommend using any invasive method for screening patients over the age of 85.  
The results of this study also showed that having a proximal tumor decreased the odds of 
being an emergency case for CRC surgery. This study is the first to report an association 
between tumor location and emergency condition for surgery for CRC. However, it has been 
reported that screening for CRC does not have a survival benefit in patients with proximal 
cancers despite recent epidemiologic studies suggesting an overall shift to more proximal sites of 
colon cancer distribution. (Wong, 2010) Proximal cancer tumor biology also makes it hard for 
them to be detected. There are underlying differences in the biology of proximal and distal CRC 
neoplasia that may contribute to the variable effectiveness of colonoscopy. (Baxter, Warren, 
Barrett, Stukel, & Doria-Rose, 2012) This may mean that proximal tumors were possibly 
underrepresented in the sample in this study. Further investigation into the association between 
tumor location and emergency condition for CRC surgery is warranted. 
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Strengths of this study include the use of population based data from a cancer registry 
that is globally recognized as an authoritative source of information on cancer incidence in the 
United States. Detailed demographic and cancer data on stage and tumor location allowed for 
multivariable regression analysis of emergency condition for CRC surgery variations in patients 
with and without diabetes that adjusted for several potential major confounders. 
Despite its strengths the limitations of the study must be acknowledged. Previously 
employed algorithms were used to identify diabetic patients. However, the study was unable to 
identify the duration of diabetes as well as clinical values such as HbA1C which may have 
significantly affected the stage at which patients were diagnosed with CRC. Siddiqui et al have 
reported that uncontrolled diabetes and therefore increased HbA1C levels leads to diagnosis of 
CRC at later stages than diabetes that is under control. (Siddiqui et al., 2008) Future studies in 
the elderly must take into consideration clinical values and duration of diabetes. The study 
population was limited to those undergoing resection procedures, and many patients presenting 
in emergency settings with CRC but who did not undergo surgery such as severe cases in which 
surgery would have been unsuccessful or the patient refused treatment, may not have been 
represented. 
 Emergency surgery for CRC can have a significant impact on the progression of the 
disease. Predictors of emergency surgery such as race, and tumor location, must be explored 
further to avoid the burden associated with the condition. Stage at diagnosis is significantly 
associated with emergency surgery, which can be avoided by regular CRC screening. 
 
 




American Cancer Society. (2011). Colorectal cancer facts & figures 2011-2013. Atlanta, GA: 
American Cancer Society.  
Baxter, N. N., Warren, J. L., Barrett, M. J., Stukel, T. A., & Doria-Rose, V. P. (2012). 
Association between colonoscopy and colorectal cancer mortality in a US cohort according to 
site of cancer and colonoscopist specialty. Journal of Clinical Oncology : Official Journal of the 
American Society of Clinical Oncology, doi:10.1200/JCO.2011.40.4772  
Coughlin, S. S., Calle, E. E., Teras, L. R., Petrelli, J., & Thun, M. J. (2004). Diabetes mellitus as 
a predictor of cancer mortality in a large cohort of US adults. American Journal of 
Epidemiology, 159(12), 1160-1167. doi:10.1093/aje/kwh161  
Coughlin, S. S., & Thompson, T. (2005). Physician recommendation for colorectal cancer 
screening by race, ethnicity, and health insurance status among men and women in the united 
states, 2000. Health Promotion Practice, 6(4), 369-378. doi:10.1177/1524839905278742  
Diggs, J. C., Xu, F., Diaz, M., Cooper, G. S., & Koroukian, S. M. (2007). Failure to screen: 
Predictors and burden of emergency colorectal cancer resection. The American Journal of 
Managed Care, 13(3), 157-164.  
Elwing, J. E., Gao, F., Davidson, N. O., & Early, D. S. (2006). Type 2 diabetes mellitus: The 
impact on colorectal adenoma risk in women. The American Journal of Gastroenterology, 
101(8), 1866-1871. doi:10.1111/j.1572-0241.2006.00651.x  
Neel Shah  Dissertation 
59 
 
Etzioni, D. A., Beart, R. W.,Jr, Madoff, R. D., & Ault, G. T. (2009). Impact of the aging 
population on the demand for colorectal procedures. Diseases of the Colon and Rectum, 52(4), 
583-90; discussion 590-1. doi:10.1007/DCR.0b013e3181a1d183  
Everhart, J. E., & Ruhl, C. E. (2009). Burden of digestive diseases in the united states part II: 
Lower gastrointestinal diseases. Gastroenterology, 136(3), 741-754. 
doi:10.1053/j.gastro.2009.01.015  
Extermann, M. (2000). Measurement and impact of comorbidity in older cancer patients. Critical 
Reviews in oncology/hematology, 35(3), 181-200.  
Faivre, J., Lemmens, V. E., Quipourt, V., & Bouvier, A. M. (2007). Management and survival of 
colorectal cancer in the elderly in population-based studies. European Journal of Cancer 
(Oxford, England : 1990), 43(15), 2279-2284. doi:10.1016/j.ejca.2007.08.008  
Felsen, C. B., Piasecki, A., Ferrante, J. M., Ohman-Strickland, P. A., & Crabtree, B. F. (2011). 
Colorectal cancer screening among primary care patients: Does risk affect screening behavior? 
Journal of Community Health, 36(4), 605-611. doi:10.1007/s10900-010-9348-0  
Gellad, Z. F., & Provenzale, D. (2010). Colorectal cancer: National and international perspective 
on the burden of disease and public health impact. Gastroenterology, 138(6), 2177-2190. 
doi:10.1053/j.gastro.2010.01.056  
Gilbert, A., & Kanarek, N. (2005). Colorectal cancer screening: Physician recommendation is 
influential advice to marylanders. Preventive Medicine, 41(2), 367-379. 
doi:10.1016/j.ypmed.2005.01.008  
Neel Shah  Dissertation 
60 
 
Giovannucci, E. (2001). Insulin, insulin-like growth factors and colon cancer: A review of the 
evidence. The Journal of Nutrition, 131(11 Suppl), 3109S-20S.  
Gloeckler Ries, L. A., Reichman, M. E., Lewis, D. R., Hankey, B. F., & Edwards, B. K. (2003). 
Cancer survival and incidence from the surveillance, epidemiology, and end results (SEER) 
program. The Oncologist, 8(6), 541-552.  
Gross, C. P., Guo, Z., McAvay, G. J., Allore, H. G., Young, M., & Tinetti, M. E. (2006). 
Multimorbidity and survival in older persons with colorectal cancer. Journal of the American 
Geriatrics Society, 54(12), 1898-1904. doi:10.1111/j.1532-5415.2006.00973.x  
Hao, Y., Jemal, A., Zhang, X., & Ward, E. M. (2009). Trends in colorectal cancer incidence rates 
by age, race/ethnicity, and indices of access to medical care, 1995-2004 (united states). Cancer 
Causes & Control : CCC, 20(10), 1855-1863. doi:10.1007/s10552-009-9379-y  
Hayanga, A. J., Mukherjee, D., Chang, D., Kaiser, H., Lee, T., Gearhart, S., et al. (2010). 
Teaching hospital status and operative mortality in the united states: Tipping point in the 
volume-outcome relationship following colon resections? Archives of Surgery (Chicago, Ill.: 
1960), 145(4), 346-350. doi:10.1001/archsurg.2010.24  
Hebert, P. L., Geiss, L. S., Tierney, E. F., Engelgau, M. M., Yawn, B. P., & McBean, A. M. 
(1999). Identifying persons with diabetes using medicare claims data. American Journal of 
Medical Quality : The Official Journal of the American College of Medical Quality, 14(6), 270-
277.  
Neel Shah  Dissertation 
61 
 
Hoff, G., & Dominitz, J. A. (2010). Contrasting US and european approaches to colorectal 
cancer screening: Which is best? Gut, 59(3), 407-414. doi:10.1136/gut.2009.192948  
Hood, S., Thompson, V. L., Cogbill, S., Arnold, L. D., Talley, M., & Caito, N. M. (2010). 
African american's self-report patterns using the national cancer institute colorectal cancer 
screening questionnaire. Journal of Cancer Education : The Official Journal of the American 
Association for Cancer Education, 25(3), 431-436. doi:10.1007/s13187-010-0068-z  
Hu, F. B., Manson, J. E., Liu, S., Hunter, D., Colditz, G. A., Michels, K. B., et al. (1999). 
Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in 
women. Journal of the National Cancer Institute, 91(6), 542-547.  
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010). Cancer statistics, 2010. CA: A Cancer Journal 
for Clinicians, 60(5), 277-300. doi:10.3322/caac.20073  
Jin, T. (2008). Why diabetes patients are more prone to the development of colon cancer? 
Medical Hypotheses, 71(2), 241-244. doi:10.1016/j.mehy.2008.03.025  
Kim, J., Mittal, R., Konyalian, V., King, J., Stamos, M. J., & Kumar, R. R. (2007). Outcome 
analysis of patients undergoing colorectal resection for emergent and elective indications. The 
American Surgeon, 73(10), 991-993.  
Klabunde, C. N., Schenck, A. P., & Davis, W. W. (2006). Barriers to colorectal cancer screening 
among medicare consumers. American Journal of Preventive Medicine, 30(4), 313-319. 
doi:10.1016/j.amepre.2005.11.006  
Neel Shah  Dissertation 
62 
 
Lemmens, V. E., Janssen-Heijnen, M. L., Verheij, C. D., Houterman, S., Repelaer van Driel, O. 
J., & Coebergh, J. W. (2005). Co-morbidity leads to altered treatment and worse survival of 
elderly patients with colorectal cancer. The British Journal of Surgery, 92(5), 615-623. 
doi:10.1002/bjs.4913  
Limburg, P. J., Anderson, K. E., Johnson, T. W., Jacobs, D. R.,Jr, Lazovich, D., Hong, C. P., et 
al. (2005). Diabetes mellitus and subsite-specific colorectal cancer risks in the iowa women's 
health study. Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American 
Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 
14(1), 133-137.  
Limburg, P. J., Vierkant, R. A., Fredericksen, Z. S., Leibson, C. L., Rizza, R. A., Gupta, A. K., et 
al. (2006). Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: A 
population-based, retrospective cohort study. The American Journal of Gastroenterology, 
101(8), 1872-1879. doi:10.1111/j.1572-0241.2006.00725.x  
McKeown-Eyssen, G. (1994). Epidemiology of colorectal cancer revisited: Are serum 
triglycerides and/or plasma glucose associated with risk? Cancer Epidemiology, Biomarkers & 
Prevention : A Publication of the American Association for Cancer Research, Cosponsored by 
the American Society of Preventive Oncology, 3(8), 687-695.  
Meissner, H. I., Breen, N., Klabunde, C. N., & Vernon, S. W. (2006). Patterns of colorectal 
cancer screening uptake among men and women in the united states. Cancer Epidemiology, 
Biomarkers & Prevention : A Publication of the American Association for Cancer Research, 
Neel Shah  Dissertation 
63 
 
Cosponsored by the American Society of Preventive Oncology, 15(2), 389-394. 
doi:10.1158/1055-9965.EPI-05-0678  
Meyerhardt, J. A., Catalano, P. J., Haller, D. G., Mayer, R. J., Macdonald, J. S., Benson, A. 
B.,3rd, et al. (2003). Impact of diabetes mellitus on outcomes in patients with colon cancer. 
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 
21(3), 433-440.  
Mitchell, A. D., Inglis, K. M., Murdoch, J. M., & Porter, G. A. (2007). Emergency room 
presentation of colorectal cancer: A consecutive cohort study. Annals of Surgical Oncology, 
14(3), 1099-1104. doi:10.1245/s10434-006-9245-z  
Mitry, E., Barthod, F., Penna, C., & Nordlinger, B. (2002). Surgery for colon and rectal cancer. 
Best Practice & Research.Clinical Gastroenterology, 16(2), 253-265. 
doi:10.1053/bega.2002.0284  
Polednak, A. P. (2000). Inpatient hospital admission through an emergency department in 
relation to stage at diagnosis of colorectal cancer. Cancer Detection and Prevention, 24(3), 283-
289.  
Potosky, A. L., Riley, G. F., Lubitz, J. D., Mentnech, R. M., & Kessler, L. G. (1993). Potential 
for cancer related health services research using a linked medicare-tumor registry database. 
Medical Care, 31(8), 732-748.  
Qaseem, A., Denberg, T. D., Hopkins, R. H.,Jr, Humphrey, L. L., Levine, J., Sweet, D. E., et al. 
(2012). Screening for colorectal cancer: A guidance statement from the american college of 
Neel Shah  Dissertation 
64 
 
physicians. Annals of Internal Medicine, 156(5), 378-386. doi:10.1059/0003-4819-156-5-
201203060-00010  
Redaelli, A., Cranor, C. W., Okano, G. J., & Reese, P. R. (2003). Screening, prevention and 
socioeconomic costs associated with the treatment of colorectal cancer. PharmacoEconomics, 
21(17), 1213-1238.  
Rich, S. E., Kuyateh, F. M., Dwyer, D. M., Groves, C., & Steinberger, E. K. (2011). Trends in 
self-reported health care provider recommendations for colorectal cancer screening by race. 
Preventive Medicine, 53(1-2), 70-75. doi:10.1016/j.ypmed.2011.05.014  
Ries, L. A., Melbert, D., Krapcho, M., Stinchcomb, D. G., Howlader, N., & Horner, M. J. 
(2007). SEER cancer statistics review, 1975-2005, national cancer institute.. Bethesda: National 
Cancer Institute.  
Rim, S. H., Seeff, L., Ahmed, F., King, J. B., & Coughlin, S. S. (2009). Colorectal cancer 
incidence in the united states, 1999-2004 : An updated analysis of data from the national 
program of cancer registries and the surveillance, epidemiology, and end results program. 
Cancer, 115(9), 1967-1976. doi:10.1002/cncr.24216  
Satariano, W. A., & Silliman, R. A. (2003). Comorbidity: Implications for research and practice 
in geriatric oncology. Critical Reviews in oncology/hematology, 48(2), 239-248.  
Schenck, A. P., Klabunde, C. N., Warren, J. L., Jackson, E., Peacock, S., & Lapin, P. (2011). 
Physician visits and colorectal cancer testing among medicare enrollees in north carolina and 
south carolina, 2005. Preventing Chronic Disease, 8(5), A112.  
Neel Shah  Dissertation 
65 
 
Shack, L. G., Rachet, B., Williams, E. M., Northover, J. M., & Coleman, M. P. (2010). Does the 
timing of comorbidity affect colorectal cancer survival? A population based study. Postgraduate 
Medical Journal, 86(1012), 73-78. doi:10.1136/pgmj.2009.084566  
Siddiqui, A. A., Spechler, S. J., Huerta, S., Dredar, S., Little, B. B., & Cryer, B. (2008). Elevated 
HbA1c is an independent predictor of aggressive clinical behavior in patients with colorectal 
cancer: A case-control study. Digestive Diseases and Sciences, 53(9), 2486-2494. 
doi:10.1007/s10620-008-0264-4  
Smothers, L., Hynan, L., Fleming, J., Turnage, R., Simmang, C., & Anthony, T. (2003). 
Emergency surgery for colon carcinoma. Diseases of the Colon and Rectum, 46(1), 24-30. 
doi:10.1097/01.DCR.0000044719.17980.4C  
Vinikoor, L. C., Long, M. D., Keku, T. O., Martin, C. F., Galanko, J. A., & Sandler, R. S. 
(2009). The association between diabetes, insulin use, and colorectal cancer among whites and 
african americans. Cancer Epidemiology, Biomarkers & Prevention : A Publication of the 
American Association for Cancer Research, Cosponsored by the American Society of Preventive 
Oncology, 18(4), 1239-1242. doi:10.1158/1055-9965.EPI-08-1031  
Warren, J. L., Klabunde, C. N., Schrag, D., Bach, P. B., & Riley, G. F. (2002). Overview of the 
SEER-medicare data: Content, research applications, and generalizability to the united states 
elderly population. Medical Care, 40(8 Suppl), IV-3-18. 
doi:10.1097/01.MLR.0000020942.47004.03  
Will, J. C., Galuska, D. A., Vinicor, F., & Calle, E. E. (1998). Colorectal cancer: Another 
complication of diabetes mellitus? American Journal of Epidemiology, 147(9), 816-825.  
Neel Shah  Dissertation 
66 
 
Wong, R. J. (2010). Marked variations in proximal colon cancer survival by race/ethnicity within 
the united states. Journal of Clinical Gastroenterology, 44(9), 625-630. 
doi:10.1097/MCG.0b013e3181c64a7a  
Yancik, R., Wesley, M. N., Ries, L. A., Havlik, R. J., Long, S., Edwards, B. K., et al. (1998). 
Comorbidity and age as predictors of risk for early mortality of male and female colon 
carcinoma patients: A population-based study. Cancer, 82(11), 2123-2134.  
  
Neel Shah  Dissertation 
67 
 
Table 1: Characteristics of CRC surgery patients by Emergency status 
Patient Characteristic Emergency p 
    No    Yes   
 
N % N % 
 Diabetes 
    
0.000 
No 14,629 77.4% 1,782 81.4% 
 Yes 4,263 22.6% 408 18.6% 
 Coronary Athero 
    
0.000 
No 14,655 77.6% 1,797 82.1% 
 Yes 4,237 22.4% 393 17.9% 
 COPD 
    
0.243 
No 16,864 89.3% 1,937 88.4% 
 Yes 2,028 10.7% 253 11.6% 
 CHF 
    
0.275 
No 16,868 89.3% 1,972 90.0% 
 Yes 2,024 10.7% 218 10.0% 
 Stage 
    
0.000 
Early 11,041 58.4% 972 44.4% 
 Late 7,851 41.6% 1,218 55.6% 
 Age Group 
    
0.000 
66-69 3,044 16.1% 339 15.5% 
 70-74 4,098 21.7% 455 20.8% 
 75-79 4,665 24.7% 435 19.9% 
 80-84 3,957 20.9% 488 22.3% 
 85 and over 3,128 16.6% 473 21.6% 
 Sex 
    
0.960 
Male 8,223 43.5% 952 43.5% 
 Female 10,669 56.5% 1,238 56.5% 
 Race 
    
0.017 
White 16,157 85.5% 1,827 83.4% 
 Black 1,447 7.7% 203 9.3% 
 Other 1,288 6.8% 160 7.3% 
 Tumor Site 
    
0.000 
Distal 8,547 45.2% 1,129 51.6% 
 Proximal 10,345 54.8% 1,061 48.4% 
 Quintile of office visits 
    
0.000 
First 3,933 20.8% 402 18.4% 
 Second 4,100 21.7% 408 18.6% 
 Third 3,898 20.6% 418 19.1% 
 Fourth 3,761 19.9% 444 20.3% 
 Fifth 3,200 16.9% 518 23.7% 
 Region in the US 
    
0.000 
WEST 7,584 40.1% 933 42.6% 
 MIDWEST 3,051 16.1% 281 12.8% 
 SOUTH 3,614 19.1% 370 16.9% 
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Table 1: Characteristics of CRC surgery patients by Emergency status 
Patient Characteristic Emergency p 
    No    Yes   
Patient Location 
    
0.005 
Big Metro 10,305 54.5% 1,284 58.6% 
 Metro 5,391 28.5% 586 26.8% 
 Urban 1,154 6.1% 123 5.6% 
 Less Urban 1,659 8.8% 159 7.3% 
 Rural 383 2.0% 38 1.7%   
TOTAL 18,892 100.0% 2,190 100.0% 
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Table 2: Characteristics of CRC surgery patients by Diabetes Status 
Patient Characteristic Diabetes p 
    No    Yes   
 
N % N % 
 Emergency 
    
0.000 
No 14,629 77.4% 4,263 81.4% 
 Yes 1,782 22.6% 408 18.6% 
 Coronary Athero 
    
0.000 
No 13,430 81.8% 3,022 64.7% 
 Yes 2,981 18.2% 1,649 35.3% 
 COPD 
    
0.000 
No 14,748 89.9% 4,053 86.8% 
 Yes 1,663 10.1% 618 13.2% 
 CHF 
    
0.000 
No 15,038 91.6% 3,802 81.4% 
 Yes 1,373 8.4% 869 18.6% 
 Stage 
    
0.154 
Early 3,761 22.9% 1,117 23.9% 
 Late 12,650 77.1% 3,554 76.1% 
 Age Group 
    
0.000 
66-69 2,601 15.8% 782 16.7% 
 70-74 3,464 21.1% 1,089 23.3% 
 75-79 3,828 23.3% 1,272 27.2% 
 80-84 3,544 21.6% 901 19.3% 
 85 and over 2,974 18.1% 627 13.4% 
 Sex 
    
0.000 
Male 6,979 42.5% 2,196 47.0% 
 Female 9,432 57.5% 2,475 53.0% 
 Race 
    
0.000 
White 14,257 86.9% 3,727 79.8% 
 Black 1,143 7.0% 507 10.9% 
 Other 1,011 6.2% 437 9.4% 
 Tumor Site 
    
0.924 
Distal 7,535 45.9% 2,141 45.8% 
 Proximal 8,876 54.1% 2,530 54.2% 
 Quintile of office visits 
    
0.000 
First 2,751 16.8% 1,584 33.9% 
 Second 3,248 19.8% 1,260 27.0% 
 Third 3,320 20.2% 996 21.3% 
 Fourth 3,541 21.6% 664 14.2% 
 Fifth 3,551 21.6% 167 3.6% 
 Continued 
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Table 2: Characteristics of CRC surgery patients by Diabetes Status 
Patient Characteristic Diabetes p 
    No    Yes   
Region in the US 
    
0.000 
WEST 6,757 41.2% 1,760 37.7% 
 MIDWEST 2,594 15.8% 738 15.8% 
 SOUTH 3,115 19.0% 869 18.6% 
 EAST 3,945 24.0% 1,304 27.9% 
 Patient Location 
    
0.079 
Big Metro 8,963 54.6% 2,626 56.2% 
 Metro 4,649 28.3% 1,328 28.4% 
 Urban 1,011 6.2% 266 5.7% 
 Less Urban 1,454 8.9% 364 7.8% 
 Rural 334 2.0% 87 1.9%   
TOTAL 16,411 100.0% 4,671 100.0% 
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Table 3: Association of Diabetes and Covariates with Emergency Condition for Surgery  
Patient Characteristic p 
  
Odds 
95% C.I.for Odds 
Sig Lower Upper 
Comorbidities Diabetes .063  0.89 0.79 1.01 
 
Atherosclerosis .003 *** 0.82 0.72 0.93 
 
COPD .001 *** 1.28 1.11 1.49 
 
CHF .927  1.01 0.85 1.19 
Stage  Late .000 *** 1.75 1.60 1.91 
Region in the US WEST .000 Referent    
 
MIDWEST .000 *** 0.75 0.65 0.87 
 
SOUTH .006 *** 0.82 0.72 0.95 
 
EAST .473  1.04 0.93 1.17 
Location of tumor Proximal .000 *** 0.78 0.71 0.85 
Age Group 66-69 .000 Referent    
 
70-74 .515  1.05 0.91 1.22 
 
75-79 .282  0.92 0.79 1.07 
 
80-84 .002 *** 1.28 1.10 1.48 
 
85 and over .000 *** 1.62 1.39 1.89 
Sex FEMALE .994  1.00 0.91 1.10 
Race White .016 Referent    
 
Black .004 *** 1.27 1.08 1.49 
 
Other .879  1.01 0.85 1.21 
Patient Location Big Metro .263 Referent    
 
Metro .047 *** 0.90 0.81 1.00 
 
Urban .333  0.91 0.74 1.11 
 
Less Urban .150  0.87 0.73 1.05 
 
Rural .664  0.93 0.65 1.31 
Quintile of Office 
Visits 
First .000 Referent    
 
Second .571  0.96 0.83 1.11 
 
Third .807  1.02 0.88 1.19 
 
Fourth .130  1.13 0.97 1.32 
  Fifth .000 *** 1.48 1.26 1.74 
*** Significant at the p = 0.05 level 
Coronary Athero = Coronary Atherosclerosis; COPD = Chronic Obstructive Pulmonary Disorder; CHF = 
Congestive Heart Failure 
Referent group for Diabetes, Coronary Atherosclerosis, COPD and CHF are No Diabetes, No Coronary 
Atherosclerosis, No COPD and No CHF respectively 
Referent group for female is male 
Referent group for proximal tumor location is distal tumor location 
First quintile in Office Visits represents highest number of office visits and fifth represents the lowest 
 
  




IMPACT OF PRE-EXISTING DIABETES ON COLORECTAL CANCER MORTALITY 
  




Mortality from colorectal cancer (CRC) has been decreasing in the past 20 years due to 
advances in both early detection and treatment. (American Cancer Society, 2011) This decline in 
cancer mortality for the US population was statistically significant in 1994 through 1998 with 
rates leveling off from 1998-2000, which may have been due to a change in the classification of 
deaths due to cancer. (Ries et al., 2007) A significant part of the overall decline in cancer 
mortality, and the resultant increase in survival, appears to be due to the success of various 
initiatives by the National Cancer Institute. Despite the significant survival benefits seen in CRC 
due to increasing screening rates, disparities in screening, treatment, and survival persist and it 
remains third in terms of cancer incidence and mortality. (Gellad & Provenzale, 2010) The 
reports of decreasing cancer mortality are specific to the cancer and do not include all-cause 
mortality. Thus, although individuals diagnosed with CRC have improved cancer-specific 
mortality, reducing all-cause mortality in CRC with comorbid conditions has become 
increasingly important. (Gross et al., 2006)  
The majority of new CRC diagnoses occur in older individuals, with more than two-
thirds diagnosed in those over the age of 65 years. (Everhart & Ruhl, 2009; Ries et al., 2007; 
Rim, Seeff, Ahmed, King, & Coughlin, 2009)Comorbidity, or illnesses other than the primary 
illness under treatment, is more common in the elderly. (Shack, Rachet, Williams, Northover, & 
Coleman, 2010) Older individuals also often present with chronic conditions that complicate the 
diagnostic and clinical management of CRC which leads to poorer prognosis and outcomes of 
the cancer. (Satariano & Silliman, 2003; Yancik et al., 1998)The three most common comorbid 
conditions seen in elderly patients with CRC are congestive heart failure, chronic obstructive 
pulmonary disease and diabetes mellitus. (Gross et al., 2006)  
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Numerous epidemiological and few pathophysiological studies have reported a positive 
association between diabetes and CRC. (Elwing, Gao, Davidson, & Early, 2006; Giovannucci, 
2001; Hu et al., 1999; Jin, 2008; Limburg et al., 2005; Limburg et al., 2006; McKeown-Eyssen, 
1994; Vinikoor et al., 2009; Will, Galuska, Vinicor, & Calle, 1998) Poorly controlled type 2 
diabetes independently predicts early onset of CRC, a more advanced stage at the time of 
presentation, and a poorer 5-year survival. (Siddiqui et al., 2008). The influence of diabetes 
mellitus on the mortality of patients with established colorectal cancer has been demonstrated by 
various authors but with conflicting conclusions. Results from a clinical trial in 2003 were the 
first to document that even after adjustment for other predictors of colon cancer, patients with 
diabetes and high-risk stage II or stage III colon cancer experienced a significantly higher rate of 
overall cancer mortality and cancer recurrence than non-diabetics. (Meyerhardt et al., 2003) Only 
one other prospective study in the United States has investigated this relationship finding a 
similar positive association. (Coughlin, Calle, Teras, Petrelli, & Thun, 2004). These studies are 
limited by either their small, younger sample that did not have other debilitating chronic diseases 
or relied on self-report data as end points. Retrospective studies have mixed conclusions about 
whether or not pre-existing diabetes affects CRC mortality. A study conducted in elderly patients 
in the Netherlands found that with co-morbidities such as diabetes, patients were treated less 
aggressively and had a worse survival than those with no concomitant disease. (Lemmens et al., 
2005). Other retrospective cohort studies have concluded that diabetes did not affect short-term 
survival or cancer specific survival, or were inconclusive. (Shonka et al., 2006) (Gross et al., 
2006; Jullumstro, Kollind, Lydersen, & Edna, 2009)  
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Treatment for cancer can greatly affect mortality and short as well as long term survival 
in patients with CRC. (Gill et al., 2004; Iwashyna & Lamont, 2002) Surgical resection is the only 
curative treatment of colorectal cancer, performed as an open, surgical procedure requiring 
hospitalization. (Mitry, Barthod, Penna, & Nordlinger, 2002; Redaelli, Cranor, Okano, & Reese, 
2003) Potentially fatal complications of colorectal cancer include bowel perforation, peritonitis, 
and obstruction. These complications are considered surgical emergencies and are the initial 
presentation of colorectal cancer in an estimated 15% to 30% of patients with colorectal cancer. 
(Diggs, Xu, Diaz, Cooper, & Koroukian, 2007). In addition, patients with emergency room 
presentation of CRC have an increased 30-day mortality and decreased 5-year survival compared 
to those scheduled for elective surgery. (Mitchell, Inglis, Murdoch, & Porter, 2007). The 
Colorectal Cancer Collaborative Group in England reported that outcomes of surgery in elderly 
patients are worse than those in younger patients because they were more likely to have 
increased frequency of comorbid conditions, later-stage at presentation with the disease, and 
undergo emergency surgery, and less likely to have curative surgery than younger patients. 
(Colorectal Cancer Collaborative Group, 2000)  
Although elective surgical resection is the curative treatment for CRC, a proportion of 
patients present as surgical emergencies, which is a sign of failure to screen in a timely fashion. 
(Rabeneck, Paszat, & Li, 2006) Patients with a new diagnosis of CRC who present with 
obstruction, or perforation, or those who require emergency admission to hospital have more 
advanced disease. (Scott, Jeacock, & Kingston, 1995). Patients who are admitted emergently also 
have worse survival rates than those who are not. (Kim et al., 2007; Paulson, Wirtalla, 
Armstrong, & Mahmoud, 2009; Smothers et al., 2003) However, these reports are however from 
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studies that have included a small sample of patients from local hospitals that are not nationally 
representative.  
Chemotherapy is used in patients at risk for metastases and those with poor prognosis 
following surgery. (Redaelli et al., 2003) Evidence from clinical trials suggests that adjuvant 
chemotherapy is associated with a 34% reduction in mortality, and population-based 
observational studies have demonstrated similar survival benefits. (Gill et al., 2004) Prior work 
also has suggested that the survival benefits associated with adjuvant therapy do not diminish 
with increasing age. (Iwashyna & Lamont, 2002) Previous evidence has shown that although a 
survival benefit was seen in diabetic patients who received chemotherapy rather than those 
diabetic patients who did not, presence of diabetes significantly reduced the use of adjuvant 
chemotherapy. (Gross, McAvay, Guo, & Tinetti, 2007) 
 Therefore, besides having a comorbid condition such as diabetes, type of treatment, 
emergency admission, stage at diagnosis, age and other comorbid conditions play an important 
role in the survival of the colorectal cancer patient. No study has examined these factors together 
in a large nationally representative sample. The primary objective of the study is to explore the 
effect of diabetes on survival of elderly Medicare beneficiaries with CRC. A secondary objective 
is to explore the association of the covariates including the three most common comorbid 
conditions, in addition to diabetes (congestive heart failure (CHF), chronic obstructive 
pulmonary disease (COPD), and coronary atherosclerosis), emergency admission, and treatment 
variables (chemotherapy/radiation and surgery), and how they affect survival in a CRC patient. 
 
 





 This retrospective cross sectional analysis employed the Surveillance, Epidemiology and 
End Results-Medicare (SEER-Medicare) files for the years 2003 to 2005. The data come from 
the SEER program of cancer registries that collect clinical, demographic, mortality and survival 
for persons with cancer and the Medicare claims for covered health care services from the time 
of a person's Medicare eligibility until death. The SEER-Medicare data reflect the linkage of two 
large population-based sources of data that provide detailed information about Medicare 
beneficiaries with cancer. The linkage of these two data sources results in a unique population-
based source of information that can be used for an array of epidemiological and health services 
research. Previous work has demonstrated excellent agreement among data sources in case 
ascertainment. (Potosky, Riley, Lubitz, Mentnech, & Kessler, 1993) Currently, SEER has 17 
high quality registries participating in the program, representing 12 states, and with the Medicare 
data it effectively represents the elderly population of the entire United States. (Warren, 
Klabunde, Schrag, Bach, & Riley, 2002)  
Cohort 
 Patients with a newly diagnosed malignant adenocarcinoma of the colon or rectum were 
identified in the SEER-Medicare database between the years 2003-2005. With the stipulated 
inclusion criteria of 1) only one primary cancer, 2) eligibility for both Part A and B benefits for 
at least 12 months prior to cancer diagnosis, and 3) did not die in the same month as their cancer 
diagnosis, there were 30,340 cases aged 66 and over. Sixty-six was selected as the cut-off to 
ensure that each person would have at least 12 months of Medicare claims prior to the diagnosis 
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of CRC. Cases with unknown race were eliminated (N= 38). Cases were further deleted if the 
source of information was from autopsy or death certificate only (N= 9). Finally, cases were 
deleted because their cancer stage was zero or unknown (N=5,059). The final cohort consists of 
25,234 patients.  
Variables 
 Diabetic patients were identified using inpatient, outpatient, and physician claims for 
each patient during a period of 12 months before diagnosis of CRC. To maximize specificity a 
patient was identified as diabetic if he or she had at least one inpatient claim or two outpatient 
claims for diabetes. (Hebert et al., 1999) This process provides a specificity of 98.8%. Comorbid 
conditions were searched using similar criteria and the three most common chronic conditions 
i.e. CHF, Coronary Atherosclerosis, and COPD were selected to be included as covariates. 
SEER reports disease stage using the third edition of the American Joint Committee on 
Cancer (AJCC) definition for the 2003 cases and AJCC Cancer Staging Manual 6th edition 
definition for cases diagnoses in 2004 and 2005. Comprehensive stage categories were collapsed 
into stages I, II, III and IV. Stage at diagnosis for colorectal cancer directly affects mortality and 
survival. Chances for survival are more than 90% for Stage I, 82% for Stage II, 57% for Stage III 
and drop to 6% for Stage IV patients. (Gloeckler Ries, L.A. 2003) Due to these differential 
survival rates between the stages, patients were categorized as being “Early Stage” (Stage I and 
II) or “Late Stage” (Stages III and IV) patients.  
Age was categorized as 66-69 years, 70-74 years, 75-79 years, 80-84 years, and 85 years 
and over. Race was categorized as white, black, and other. SEER areas to which the patients 
belonged were categorized as west, mid-west, south, and east depending on the region in the US. 
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Location of the tumor was categorized as proximal (cecum to splenic flexure) and distal 
(descending colon to rectum). The categorization was based on the ease of cancer detection 
based on the method used for screening or diagnosis. Proximal cancers are identified primarily 
through the use of colonoscopy, unlike a sigmoidoscopy which would be unable to reach these 
areas. The number of physician office visits 12 months prior to cancer diagnosis was identified 
and the continuous variable was transformed into quintiles of office visits with the first quintile 
representing the highest number of office visits. Patients admitted emergently were identified as 
“emergency admission”. 
 Surgery for CRC, within 12 months after cancer diagnosis, was identified by using the 
International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) 
procedure codes for colon resection  (codes 45.7x and 45.8), rectal resection (codes 48.4x, 48.5, 
48.6x), and other operations on the intestine including colostomy and ileostomy (codes 46.1-2). 
(Diggs et al., 2007; Etzioni, Beart, Madoff, & Ault, 2009; Hayanga et al., 2010) Since radiation 
claims formed only a small percentage of treatment claims in the Medicare files, chemotherapy 
and radiation received within 12 months after cancer diagnosis were collapsed to create the 
variable “chemotherapy/radiation”. 
Statistical Analysis 
 The advantage of using survival statistics is that it considers when the patient was 
diagnosed, stage at diagnosis and the kind of treatment given in the stipulated time period. (Ries 
2007) Patients that were newly diagnosed with CRC between 2003 and 2005 were examined up 
December 31st 2007 in this study which gives a follow up period of up to 5 years or 60 months.  
Mortality, on the other hand measures deaths due to cancer in a given time period, irrespective of 
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when patients were diagnosed, and does not take into consideration treatment options. (Ries 
2007) Hence for this study survival analysis techniques were employed. 
 Univariate statistics were used to describe the sample and bivariate statistics were used 
to explore the proportion of patients distributed between diabetics and nondiabetics. Pearson’s 
chi-square statistic was used for the bivariate analysis. Cox proportional hazards models were 
used to examine the association between each patient characteristic and all cause mortality 
during the follow-up period. Data were censored at death or the end of calendar year 2007, 
whichever occurred first. Candidate covariates for the multivariate model included 
sociodemographic characteristics, cancer-specific characteristics (stage, tumor location), and 
individual conditions. To address variability in use of care the number of physician outpatient 
visits 12 months before cancer diagnosis was included in the model. To determine whether 
treatment differences mediated the relationship between specific chronic conditions and death, 
the analysis was repeated after adding cancer treatment–related variables to the model. All 
analyses were performed using IBM SPSS version 20.  
 
Results 
 In a sample of 25,234 patients with newly diagnosed CRC from 2003 to 2005 there were 
5.466 diabetics (21.7%). The mean age of the study cohort was 77.5 years (range 66 to 114) and 
there were 55.1% females. Patients were evenly distributed between all stages with 25% 
diagnosed at stage I, 30.4% at stage II, 26.1% at stage III, and 18.5% at stage IV. Tumors were 
equally divided as well, with 50.2% located in the proximal area of the colon. There were 18.0% 
patients who were admitted emergently. 
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 Table 1 shows the distribution of patients by patient characteristic. The highest 
proportion of patients by age belonged to 75-79 years group (23.8%), and a majority of the 
patients were white (84.8%). Presence of coronary atherosclerosis, COPD and CHF were 21.5%, 
11.1%, and 10.9% respectively. Emergency admission was represented by 18.0% of the cohort. 
Most of the newly diagnosed patients underwent surgery (83.5%), and the number of patients 
that received chemotherapy or radiation was 34.5%. A majority of patients belonged to Western 
US (40.6%) and resided in a large metropolitan area (55.1%). 
 Distribution of patients by diabetes status shows that with increasing age prevalence of 
diabetes increases, peaks between ages 75-79 years and then declines thereafter (Table 2). There 
were more diabetic males than females, and compared to Whites, Blacks, or Other races tended 
to have a greater proportion of the disease. Although diabetics were more likely to be diagnosed 
at early stages, they were also more likely to be admitted emergently. A greater proportion of 
diabetics underwent surgery for CRC with no difference seen in chemotherapy or radiation 
treatments between diabetics and nondiabetics. Diabetics also had a higher frequency of 
physician office visits than nondiabetics.  
 Table 3 shows the proportions of patients who died by comorbid conditions, treatment 
variables and demographic characteristics. Diabetic patients were significantly more likely to die 
within the five year period than nondiabetics, Similar results were seen in patients suffering from 
coronary atherosclerosis, COPD and CHF. Patients with late stage at diagnosis and distal tumor 
location were also more significantly more likely to die than those with early stage diagnosis and 
proximal tumors. Patients admitted emergently were more likely to die than those who were not. 
In this bivariate analysis although surgery had a beneficial effect on mortality, chemotherapy or 
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radiation did not. Finally only patients with the greatest number of office visits were more likely 
to die compared to those with the lowest number of office visits. 
 The mortality risk (represented by hazard ratios or HR in Table 4) associated with 
diabetes in the cox proportional hazards model was significantly greater for diabetics than 
nondiabetics (HR 1.15, 95% CI 1.09-1.20). This was seen for COPD (HR 1.33, 95% CI 1.26-
1.41) and CHF (HR 1.43, 95% CI 1.35-1.52). Risk of mortality significantly increased with age 
with the HR for those over the age of 85 being more than twice as compared to those between 
66-69 years (HR 2.30, 95% CI 2.14-2.47). Women had a lower risk than men (HR 0.92 955 CI 
0.89-0.96) and Blacks had an 8% higher risk than Whites (HR 1.08, 95%CI 1.01-1.15). 
Presenting emergently significantly increased the risk of mortality (HR 1.61, 95% CI 1.54-1.68). 
Surgery significantly reduced the risk of mortality (HR 0.41, 95% CI 0.39-0.43) and although in 
bivariate analyses patients who received chemotherapy were more likely to die, the hazard model 
showed a significant benefit associated with chemotherapy or radiation (HR 0.70, 95% CI 0.67-
0.74). Patients with the highest number of office visits had improved risk of mortality compared 
to those with lower number of office visits.  
 Kaplan-Meier survival curves for diabetics, emergency admission patients, patients who 
underwent surgery and chemotherapy/radiation recipients are shown in Figs 1-4. The survival 
curve for surgery clearly shows a benefit beginning in the first year itself. Although there is a 
benefit seen in patients receiving chemotherapy/radiation, it is more pronounced only in later 
years. Diabetics clearly had a poorer survival benefit compared to nondiabetics which worsened 
with time. Those who were admitted emergently had lower survival from the time of diagnosis 
which progressively worsened with time compared to those who were not admitted emergently. 





 This study was conducted to explore the effect of diabetes on survival of elderly 
Medicare beneficiaries with CRC. The study also explores the association of the covariates 
including the three most common comorbid conditions (coronary atherosclerosis, CHF, and 
COPD), in addition to diabetes, emergency admission, and treatment variables and how they 
affect survival in a CRC patient. 
 The study shows that diabetics suffered worse mortality and survival than nondiabetics. 
Several factors need to be considered while interpreting this result. First, lack of mortality as 
well as survival benefit in diabetics is seen despite them being in the highest bracket of physician 
office visits. Increased number of office visits and visits with primary care physicians in elderly 
Medicare beneficiaries have previously been associated with increased CRC test use. (Schenck et 
al., 2011) Klabunde and colleagues have reported that having a chronic condition such as 
diabetes is a predictor of receiving a physician recommendation for CRC screening. (Klabunde, 
Schenck, & Davis, 2006)(Klabunde et al., 2006) Increased number of physician office visits 
increases the chances of being recommended for a screening test and clinician recommendation 
for a screening test has been proven to be a strong predictor of adherence to CRC screening in 
the elderly as well as young patients to adhere to screening practices for CRC. (Felsen, Piasecki, 
Ferrante, Ohman-Strickland, & Crabtree, 2011; Gilbert & Kanarek, 2005) Second, although 
diabetics visited physician offices more frequently they were also admitted more emergently for 
CRC than non-diabetics. This study shows that there is a significant mortality risk associated 
with being admitted emergently. Besides being a sign of screening failure, emergent admissions 
have poorer outcomes than non-emergent admissions for CRC. Last, despite controlling for the 
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treatment variables surgery and chemotherapy/radiation, which provide significant survival 
benefit, the study shows a decrease in survival benefit in diabetics.  
 Although it has been advised that among CRC patients, preexisting diabetes is associated 
with a higher risk of all-cause long-term mortality, this is the first study that explores this 
association in light of the aforementioned factors. Besides these factors it has been shown that 
because diabetes can lead to infections, metabolic derangements, and acute cardiovascular 
events, cancer patients, including those with CRC, diabetics may also be at a greater risk of 
short-term mortality, especially while surgery is being performed and even after surgery. 
(Richardson & Pollack, 2005) A recent meta-analysis by Barone and colleagues concluded that 
compared to nondiabetics, cancer patients with preexisting diabetes are approximately 50% more 
likely to die after surgery. (Barone et al., 2010) They mention that this could be due to sepsis and 
other serious infections which could increase in diabetics especially after surgery due to a 
possible rise in blood sugar levels. 
 This study shows that patients with fewer office visits had a survival benefit. This could 
be explained by the fact that those with fewer office visits had fewer comorbid conditions in the 
first place and hence were predisposed to having a better prognosis and outcome. In addition, it 
has also been previously reported that elderly patients with CRC increase rather than decrease 
contact with primary care providers after diagnosis which continues through the first 5 years 
after cancer diagnosis. (Dobie, Saver, Wang, Green, & Baldwin, 2011) However, this still does 
not fully explain the reason for lack of survival benefit seen in those with the highest frequency 
of office visits. This is an issue for further research that needs to be explored. 
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 This study is the first to report emergency admission and its risk associated with mortality 
and survival in a large group of elderly, nationally representative population of CRC patients. 
Despite implementation of national intervention strategies, up to 30% percent of CRC patients 
are admitted emergently. (Kim et al., 2007; Polednak, 2000; Smothers et al., 2003) In this study 
diabetics presented more emergently than not. This clearly signifies failure to screen in a timely 
fashion and a possible failure of screening interventions and strategies. Diabetics also have worse 
survival than nondiabetics. Since diabetic CRC patients have worse outcomes than their 
nondiabetic counterparts they must take advantage of the fact that the cancer can be prevented 
with timely screening. Current screening guidelines do not consider diabetics as a special case 
for earlier screening or more frequent CRC screening. McBean and Yu have reported that elderly 
diabetic women are less likely than elderly non-diabetic women to receive colorectal cancer 
screening in the 11 SEER areas studied between 1999-2002. (McBean & Yu, 2007) They have 
furthered the argument in favor of altering CRC screening guidelines for diabetics by mentioning 
that the American Diabetes Association (ADA) should include specific screening 
recommendation for such cancers in the Standards of Medical Care in Diabetes. They also 
suggest combining specific recommendations for people with diabetes in guidelines from federal 
or national organizations that promote the use of screening services but are not primarily or 
uniquely concerned with diabetes such as the CDC, the National Cancer Institute, the American 
Cancer Society, and the CMS. 
 This study has some limitations which must be considered in the interpretation of 
results. The study used previously employed algorithms to identify diabetic patients. However, 
the duration of diabetes as well as clinical values such as HbA1C which may have significantly 
affected the stage at which patients were diagnosed with CRC, were not available. Siddiqui et al 
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have reported that uncontrolled diabetes and therefore increased HbA1C levels leads to diagnosis 
of CRC at later stages than diabetes that is under control. (Siddiqui et al., 2008) Timely 
screening plays a crucial role in detecting the cancer at earlier stages and the data did not allow 
us to check for frequency of screening. This is especially true for sigmoidoscopy and 
colonoscopy procedures which are recommended to be performed at five year and ten year 
intervals, respectively. In addition, SEER–Medicare data do not include other important 
measures of health status, such as body mass index, diet, functional disabilities or geriatric 
syndromes. 
The study also has several strengths including stringent inclusion and exclusion criteria, 
and the use of population based data from a cancer registry that is globally recognized as an 
authoritative source of information on cancer incidence in the United States. Detailed 
demographic, cancer data on stage and tumor location, and treatment variables allowed the 
construction of a strong Cox proportional hazards model to study and understand the mortality 
risk associated with diabetes and the several covariates in CRC patients. 
Diabetes has a poor effect on the survival and all-cause mortality of patients with CRC. 
Emergency admission and stage at diagnosis has a large effect on survival and therefore 
underscore the importance of early diagnosis. Diabetic patients should be screened and 
diagnosed in a timely fashion to prevent CRC or to have a better disease prognosis.   
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Table 1. Characteristics of the sample* 
Characteristic N % 
Age 
  66-69 4031 16.0 
70-74 5411 21.4 
75-79 6017 23.8 
80-84 5302 21.0 
85 & over 4473 17.7 
Sex 
  Male 11329 44.9 
Female 13905 55.1 
Race 
  White 21396 84.8 
Black 2097 8.3 
Other 1741 6.9 
Diabetes 
  No 19768 78.3 
Yes 5466 21.7 
Athero 
  No 19797 78.5 
Yes 5437 21.5 
COPD 
  No 22443 88.9 
Yes 2791 11.1 
CHF 
  No 22474 89.1 
Yes 2760 10.9 
Stage 
  Early 6312 25.0 
Late 18922 75.0 
Emergency Admission 
  No 20699 82.0 
Yes 4535 18.0 
Surgery 
  No 4152 16.5 
Yes 21082 83.5 
Chemotherapy/Radiation 
  No 16522 65.5 
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Table 1. Characteristics of the sample* 
Region in US 
  West 10245 40.6 
Midwest 3947 15.6 
South 4756 18.8 
East 6286 24.9 
Patient Location 
  Big Metro 13913 55.1 
Metro 7071 28.0 
Urban 1556 6.2 
Less Urban 2188 8.7 
Rural 506 2.0 
*Sample equals 25,234 CRC patients 
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Table 2 Characteristics of patients by diabetes status 
Patient Characteristic Diabetes p 
 
No  Yes 
   N % N %   
Age Group 
    
0.000 
66-69 3135 15.9% 896 16.4% 
 70-74 4154 21.0% 1257 23.0% 
 75-79 4561 23.1% 1456 26.6% 
 80-84 4239 21.4% 1063 19.4% 
 85 & over 3679 18.6% 794 14.5% 
 Sex 
    
0.000 
Male 8718 44.1% 2611 47.8% 
 Female 11050 55.9% 2855 52.2% 
 Race 
    
0.000 
White 17050 86.3% 4346 79.5% 
 Black 1491 7.5% 606 11.1% 
 Other 1227 6.2% 514 9.4% 
 Atherosclerosis 
    
0.000 
No 16273 82.3% 3524 64.5% 
 Yes 3495 17.7% 1942 35.5% 
 COPD 
    
0.000 
No 17729 89.7% 4714 86.2% 
 Yes 2039 10.3% 752 13.8% 
 CHF 
    
0.000 
No 18076 91.4% 4398 80.5% 
 Yes 1692 8.6% 1068 19.5% 
 Stage 
    
0.207 
Early 10917 55.2% 3071 6.2% 
 Late 8851 44.8% 2395 43.8% 
 Tumor Location  
   
0.681 
Distal 9852 49.8% 2707 49.5% 
 Proximal 9916 50.2% 2759 50.5% 
 Emergency Admission 
    
0.004 
No 16288 82.4% 4411 80.7% 
 Yes 3480 17.6% 1055 19.3% 
 Surgery 
    
0.000 
No 3357 17.0% 795 14.5% 
 Yes 16411 83.0% 4671 85.5% 
 ChemRad 
    
0.302 
No 12911 65.3% 3611 66.1% 
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Table 2 Characteristics of patients by diabetes status 
Patient Characteristic Diabetes p 
 
No  Yes 
   N % N %   
Region in the US 
    
0.000 
West 8181 41.4% 2064 37.8% 
 Midwest 3079 15.6% 868 15.9% 
 South 3733 18.9% 1023 18.7% 
 East 4775 24.2% 1511 27.6% 
 Patient Location 
    
0.141 
Big Metro 10838 54.8% 3075 56.3% 
 Metro 5539 28.0% 1532 28.0% 
 Urban 1241 6.3% 315 5.8% 
 Less Urban 1748 8.8% 440 8.0% 
 Rural 402 2.0% 104 1.9% 
 Quintile of Physician 
Visits 
    
0.000 
First (Highest) 3230 16.3% 1867 34.2% 
 Second 3767 19.1% 1465 26.8% 
 Third 3853 19.5% 1130 20.7% 
 Fourth 4125 20.9% 782 14.3% 
 Fifth (Lowest) 4793 24.2% 222 4.1%   
*Patients are representative of 19,768 nondiabetics and 5,466 diabetics 
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Table 3 Characteristics of patients by mortality status 
Patient Characteristic Died p 
 
No  Yes 
   N % N %   
Age Group 
    
0.000 
66-69 2755 19.6% 1276 11.4% 
 70-74 3435 24.4% 1976 17.7% 
 75-79 3505 24.9% 2512 22.5% 
 80-84 2702 19.2% 2600 23.3% 
 85 & over 1683 12.0% 2790 25.0% 
 Sex  
   
0.182 
Male 6269 44.5% 5060 45.4% 
 Female 7811 55.5% 6094 54.6% 
 Race  
   
0.000 
White 11979 85.1% 9417 84.4% 
 Black 1032 7.3% 1065 9.5% 
 Other 1069 7.6% 672 6.0% 
 Diabetes 
    
0.000 
No 11191 79.5% 8577 76.9% 
 Yes 2889 20.5% 2577 23.1% 
 Atherosclerosis  
   
0.000 
No 11302 80.3% 8495 76.2% 
 Yes 2778 19.7% 2659 23.8% 
 COPD  
   
0.000 
No 12867 91.4% 9576 85.9% 
 Yes 1213 8.6% 1578 14.1% 
 CHF 
    
0.000 
No 13059 92.7% 9415 84.4% 
 Yes 1021 7.3% 1739 15.6% 
 Stage  
   
0.000 
Early 9977 70.9% 4011 36.0% 
 Late 4103 29.1% 7143 64.0% 
 Tumor location  
   
0.022 
Distal 6917 49.1% 5642 50.6% 
 Proximal 7163 50.9% 5512 49.4% 
 Emergency Admission  
   
0.000 
No 12293 87.3% 8406 75.4% 
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Table 3 Characteristics of patients by mortality status 
Patient Characteristic Died p 
 
No  Yes 
   N % N %   
Surgery 
    
0.000 
No 1426 10.1% 2726 24.4% 
 Yes 12654 89.9% 8428 75.6% 
 Chemo-Radiation  
   
0.001 
No 9349 66.4% 7173 64.3% 
 Yes 4731 33.6% 3981 35.7% 
 Region in the US 
    
0.000 
West 5843 41.5% 4402 39.5% 
 Midwest 2245 15.9% 1702 15.3% 
 South 2515 17.9% 2241 20.1% 
 East 3477 24.7% 2809 25.2% 
 Patient Location 
    
0.615 
Big Metro 7717 54.8% 6196 55.5% 
 Metro 3997 28.4% 3074 27.6% 
 Urban 877 6.2% 679 6.1% 
 Less Urban 1208 8.6% 980 8.8% 
 Rural 281 2.0% 225 2.0% 






First (Highest) 2443 17.4% 2654 23.8% 
 Second 2961 21.0% 2271 20.4% 
 Third 2969 21.1% 2014 18.1% 
 Fourth 3014 21.4% 1893 17.0% 
 Fifth (Lowest) 2693 19.1% 2322 20.8%   
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Table 4. Cox Proportional Hazards Model for time to mortality in CRC patients 
over a 5 year period 
  HR 
95.0% CI for HR 
  Patient Characteristic Lower Upper p Sig 
Comorbidities Diabetes 1.12 1.06 1.17 .000 *** 
 
Atherosclerosis 0.98 0.94 1.03 .482  
 
COPD 1.33 1.26 1.41 .000 *** 
 
CHF 1.43 1.35 1.52 .000 *** 
Age Group 66-69    .000 *** 
 
70-74 1.18 1.10 1.27 .000 *** 
 
75-79 1.42 1.33 1.52 .000 *** 
 
80-84 1.72 1.60 1.84 .000 *** 
 
85 and over 2.30 2.14 2.47 .000 *** 
Sex FEMALE 0.92 0.89 0.96 .000 *** 
Race White    .000 *** 
 
Black 1.08 1.01 1.15 .020 *** 
 
Other 0.85 0.78 0.92 .000 *** 
Admission Type 
Emergency 1.61 1.54 1.68 .000 *** 
Treatment Surgery 0.41 0.39 0.43 .000 *** 
 
Chemo/Rad 0.70 0.67 0.74 .000 *** 
Tumor Location Proximal 0.94 0.91 0.98 .003 *** 
Stage Late Stage 3.74 3.59 3.91 .000 *** 
Region in the US WEST    .000 *** 
 
MIDWEST 0.97 0.91 1.03 .252  
 
SOUTH 1.11 1.05 1.18 .000 *** 
 
EAST 0.93 0.88 0.97 .002 *** 
Patient Location Big Metro    .663  
 
Metro 0.92 0.80 1.05 .214  
 
Urban 0.93 0.81 1.06 .273  
 
Less Urban 0.95 0.82 1.11 .530  
 
Rural 0.94 0.82 1.09 .420  




   .000  
 
Second 0.89 0.84 0.94 .000 *** 
 
Third 0.87 0.82 0.92 .000 *** 
 
Fourth 0.84 0.79 0.90 .000 *** 
  Fifth (Lowest) 0.93 0.87 1.00 .042 *** 
Referent categories for Diabetes, COPD, Athero and CHF are no diabetes, no 
Athero, no COPD and no CHF 
Referent category for sex is MALE, Tumor location is distal, Stage is early stage, 
and for treatment is no surgery and no Chemo/rad 









P = 0.000 








Non-Emergency P = 0.000 










P = 0.000 















P = 0.000 






To explore the outcomes of CRC in diabetic elderly patients the study used a large 
nationally representative sample and focused on main aims.  The first aim was to investigate the 
association between diabetes and stage at diagnosis of CRC in an elderly population.  The 
association of covariates such as the three most common comorbidities: coronary atherosclerosis, 
chronic obstructive pulmonary disease (COPD), and congestive heart failure (CHF); age; race; 
sex; region in the US; patient location; and the frequency of physician office visits with stage at 
CRC diagnosis was also evaluated.  
 The second aim was to check the association of diabetes with CRC presenting as an 
emergency condition for surgery in the elderly. This was followed by an investigation of 
predictors of emergency condition of CRC surgery in the elderly using large nationally 
representative registry data. The predictors that were explored included were the three most 
common comorbidities: coronary atherosclerosis, chronic obstructive pulmonary disease 
(COPD), and congestive heart failure (CHF); age; race; sex; region in the US; patient location; 
the frequency of physician office visits; and stage at CRC diagnosis. 
 Finally, the study explored the effect of diabetes on survival of elderly Medicare 
beneficiaries with CRC. It also explored the association of the covariates including three most 
common comorbid conditions, in addition to diabetes, emergency admission, and treatment 
variables and how they affect survival in a CRC patient. 
 For all three aims, the linked Surveillance, Epidemiology and End-Results (SEER)-
Medicare data which is a large population-based source of information for cancer-related 
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epidemiologic and health services research was utilized. The use of the SEER-Medicare data 
consists of CRC cases from 17 registries from 2003-2005, and provides several strengths such as 
exploring a nationally representative elderly population. This is unique since previous studies 
have studied the disease in either smaller regions of the country, fewer registries, or have 
included patients that were not elderly.  This is also the first study to explore the association of 
diabetics with stage at diagnosis of CRC in such a large representative sample in the US. The 
association of diabetes with emergency condition for CRC surgery including bowel perforation, 
bowel obstruction, and peritonitis has never before been studied in an elderly population; this 
study investigates this along with relevant covariates. The association of diabetes, other 
frequently seen chronic comorbid conditions, emergency admissions and treatment variable, 
along with tumor location, office visits, region and other demographic characteristics finally 
come together to check survival and mortality in this unique sample. 
 
Diabetes and Stage at Diagnosis 
 The association of diabetes with stage at diagnosis of CRC has been previously 
studied in the US and other countries in smaller samples with conflicting results. In this study 
diabetes does not show a significant association with stage at diagnosis for CRC. If left 
uncontrolled, diabetes outcomes in CRC patients are even worse than those with controlled 
diabetes. (Siddiqui, A.A. 2008) In addition, diabetic CRC patients tend to have poorer outcomes 
than non-diabetic patients, and therefore it can be argued that the cancer should be detected at an 
earlier stage in diabetics than in non-diabetics due to the survival benefit provided at being 
treated at earlier stages.  
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This study also showed that diabetics visited physicians more frequently than non-
diabetics and were more likely to have comorbid conditions such as coronary atherosclerosis, 
COPD and CHF. This would predispose them to greater recommendations for screening for 
various diseases including CRC and therefore it would be reasonable to expect them to be 
diagnosed at earlier stages than non-diabetics. However, after adjusting for the number of 
physician office visits this was not so. A review of barriers and facilitators to screening for CRC 
in patients over the age of 65 suggests that although Medicare's coverage 
of screening colonoscopy was consistently reported as a facilitator, the most cited barrier was 
lack of screening recommendation by a physician. (Guessous, I. 2010) Compared to average risk 
patients, i.e. patients over the age of 50 with no chronic diseases or history of cancer, diabetics 
are considered as increased-risk for colorectal cancer. A recent study that examined screening 
patterns in individuals with varying risk for CRC found that compared to average risk patients, 
diabetics were less likely to be recommended by physicians for CRC screening and were also 
less likely to be adherent to a recommendation if one was made. (Felsen, C.B. 2011)  
It is important to note that patients over the age of 80 are more likely to be diagnosed at a 
later stage than younger patients. This could be due to some guidelines cautioning against use of 
invasive methods for screening for patients over the age of 75 due to possible adverse effects of 
screening. (Qaseem,A. 2012)  All guidelines specifically do not recommend using any invasive 
method for screening patients over the age of 85. 
 The results in this study show that tumors detected within the proximal region in the 
colon are found to have progressed much more than the ones located in the distal region. Distal 
tumors are easier to detect with less invasive procedures such as sigmoidoscopy which cannot 
look at the large intestine in its entirety and is recommended more frequently than colonoscopies. 
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Although, both invasive procedures are equally sensitive, sigmoidoscopes cannot reach the 
proximal areas of the large intestine leading to tumors in those areas to go undetected. (Schoen, 
R.E. 2012) Proximal tumor location, even after controlling for stage, has also been significantly 
associated with poorer mortality and survival as compared to distally located colon cancers. 
(Wray, C.M. 2009)  
 
Diabetes and Emergency Condition for CRC surgery 
 This study is the first to report the association of diabetes with emergency surgery 
for CRC, and explore the predictors of emergency colorectal cancer surgery in a large nationally 
representative sample. The study showed that the odds of being an emergency patient for CRC 
surgery were lower for diabetic patients; this association was not significant. However, this result 
must be interpreted in light of the fact that diabetic patients belonged to the highest quintile in 
terms of physician office visits. Previous reports on a Medicare population have mentioned that  
having any physician office visit, increased number of office visits, and visits with primary care 
physicians were associated with increased CRC test use.(Schenck et al., 2011)  Klabunde and 
colleagues have reported that having a chronic condition such as diabetes is a predictor of 
receiving a physician recommendation for CRC screening.(Klabunde, Schenck, & Davis, 2006)  
Increased number of physician office visits increases the chances of being recommended for a 
screening test; and clinician recommendation for a screening test has been proven to be a strong 
predictor in the elderly as well as young patients to adhere to screening practices for 
CRC.(Felsen, Piasecki, Ferrante, Ohman-Strickland, & Crabtree, 2011; Gilbert & Kanarek, 
2005) 
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Compared to Whites, Black patients were more likely to be classified as an emergency 
condition for CRC surgery. It has been reported that Blacks, Hispanics, and American 
Indians/Alaska Natives were less likely to report receiving a recommendation for sigmoidoscopy 
compared to Whites.(Coughlin & Thompson, 2005) Whites are also more likely than Blacks to 
report ever receiving a provider recommendation for a colonoscopy. Although the proportion of 
patients receiving recommendations for colonoscopy/sigmoidoscopy increased over time, the gap 
between races remained unchanged, even after controlling for insurance status.(Rich et al., 2011) 
A study by Hood and colleagues has reported that although over 80% of their sample of 439 
blacks was covered by insurance, less than 50% reported receiving a recommendation to screen 
for CRC.(Hood et al., 2010)  
Once again the intermediate outcome for the elderly patients over the age of 80 was 
poorer with the odds of being an emergency case for CRC surgery being higher for  this group. 
This could, again, be due to several guidelines cautioning against use of invasive methods for 
screening for patients over the age of 75 and all guidelines specifically not recommending using 
any invasive method for screening patients over the age of 85 due to possible adverse effects of 
screening.(Qaseem et al., 2012)   
The results of this study also showed that having a proximal tumor decreased the odds of 
being an emergency case for CRC surgery. This study is the first to report an association 
between tumor location and emergency condition for surgery for CRC. However, it has been 
reported that screening for CRC does not have a survival benefit in patients with proximal 
cancers despite recent epidemiologic studies suggesting an overall shift to more proximal sites of 
colon cancer distribution.(Wong, 2010) Proximal cancer tumor biology also makes it hard for 
them to be detected. There are underlying differences in the biology of proximal and distal CRC 
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neoplasia that may contribute to the variable effectiveness of colonoscopy.(Baxter, Warren, 
Barrett, Stukel, & Doria-Rose, 2012) This may mean that proximal tumors were possibly 
underrepresented in the sample in this study.  
Diabetics and CRC mortality and survival 
In the analysis to explore the effect of diabetes on survival of elderly Medicare 
beneficiaries with CRC which also investigated the association of the covariates including three 
most common comorbid conditions, in addition to diabetes, emergency admission, and treatment 
variables, the study shows that diabetics suffered worse mortality and survival than nondiabetics. 
Several factors need to be considered while interpreting this result. Firstly, lack of mortality as 
well as survival benefit in diabetics is seen despite them being in the highest bracket of physician 
office visits. Increased number of office visits, and visits with primary care physicians in elderly 
Medicare beneficiaries have previously been associated with increased CRC test use. (Schenck et 
al., 2011) Klabunde and colleagues have reported that having a chronic condition such as 
diabetes is a predictor of receiving a physician recommendation for CRC screening. (Klabunde, 
Schenck, & Davis, 2006)(Klabunde et al., 2006) Increased number of physician office visits 
increases the chances of being recommended for a screening test; clinician recommendation for 
a screening test has been proven to be a strong predictor in the elderly as well as young patients 
to adhere to screening practices for CRC. (Felsen, Piasecki, Ferrante, Ohman-Strickland, & 
Crabtree, 2011; Gilbert & Kanarek, 2005)  
Secondly, although diabetics were the most frequent visitors to physician offices they 
were also admitted more emergently for CRC than non-diabetics. This study shows that there is a 
significant mortality risk associated with being admitted emergently. Besides being a sign of 
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screening failure, emergent admissions have poorer outcomes than non-emergent admissions for 
CRC.  
Lastly, despite controlling for the treatment variables surgery and 
chemotherapy/radiation, which provide significant survival benefit, the study shows a decrease 
in survival benefit in diabetics. Although it has been advised that among CRC patients, 
preexisting diabetes is associated with a higher risk of all-cause long-term mortality, this is the 
first study that explores this association in light of the aforementioned factors.  
Besides these factors it has been shown that because diabetes can lead to infections, 
metabolic derangements, and acute cardiovascular events, cancer patients, including those with 
CRC and diabetes may also be at greater risk of short-term mortality, especially while surgery is 
being performed, and even after surgery. (Richardson & Pollack, 2005) A recent meta-analysis 
by Barone and colleagues has concluded that compared to nondiabetics, cancer patients with 
preexisting diabetes are approximately 50% more likely to die after surgery. (Barone et al., 2010) 
They mention that this could be due to sepsis and other serious infections which could increase 
in diabetics especially after surgery due to a possible rise in blood sugar levels. 
 This study is the first to report emergency admission and its risk associated with mortality 
and survival in a large group of elderly, nationally representative population of CRC patients. 
Despite implementation of national intervention strategies up to 30% percent of CRC patients are 
admitted emergently. (Kim et al., 2007; Polednak, 2000; Smothers et al., 2003) In this study 
diabetics presented more emergently than not. This clearly signifies failure to screen in a timely 
fashion and a possible failure of screening interventions and strategies. Diabetics also have worse 
survival than nondiabetics.  




This study must also be interpreted in the lights of its limitations. The study used 
previously employed algorithms to identify diabetic patients. However, the duration of diabetes 
as well as clinical values such as HbA1C which may have significantly affected the stage at 
which patients were diagnosed with CRC, were not available. Siddiqui et al have reported that 
uncontrolled diabetes and therefore increased HbA1C levels leads to diagnosis of CRC at later 
stages than diabetes that is under control.(Siddiqui et al., 2008) Most colorectal cancers start off 
as benign adenomatous polyps that turn into adenocarcinomas over several years (cancers that 
begin in cells that make and release mucus and other fluids). As many as 50% of the Western 
populations develop adenomatous polyps in their lifetime but the lifetime risk for colon cancer is 
about 5% and only one in ten adenomas lead to cancer formation (Holt, Kozuch, & Mewar, 
2009). It cannot be determined which individuals with adenomas (or a histologically normal 
colon at risk for adenoma and cancer formation) will develop a cancer and therefore, preventive 
methods use detection and removal of benign neoplastic colorectal adenomas which lowers colon 
cancer formation and mortality (Muller & Sonnenberg, 1995). This study was unable to 
determine the duration and size of benign polyps, if any, in this sample which may have 
influenced the time at which the cancer was detected, the stage and the prognosis of the disease. 
Timely screening plays a crucial role in detecting the cancer at earlier stages and the data 
did not allow us to check for frequency of screening. This is especially true for sigmoidoscopy 
and colonoscopy procedures which are recommended to be performed at five year and ten year 
intervals respectively. In addition, SEER–Medicare data do not include other important measures 
of health status, such as body mass index, diet, functional disabilities or geriatric syndromes. 
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Conclusions and Future directions 
This study has several strengths including stringent inclusion and exclusion criteria, and 
the use of population based data from a cancer registry that is globally recognized as an 
authoritative source of information on cancer incidence and in the United States. Detailed 
demographic, cancer data on stage and tumor location, and treatment variables allowed the 
construction of a strong cox proportional hazards model to study and understand the mortality 
risk associated with diabetes and the several covariates in CRC patients. 
The association between diabetes and stage at colorectal cancer, although not statistically 
significant in this study, must be further explored. Dialogue between the physician and diabetic 
patient should be encouraged to discuss screening for CRC. Diabetic patients should be screened 
for the cancer either more frequently or begin at an age earlier than the average risk patient in 
order to detect the cancer at earlier stages. Patient physician interaction is of prime importance 
and there needs to be improved intervention and strategies for escalating physician 
recommendation in this subgroup of the population.  
This study shows that patients with fewer office visits had a survival benefit. This could 
be explained by the fact that those with fewer office visits had fewer comorbid conditions in the 
first place and hence were predisposed to having a better prognosis and outcome. In addition, it 
has also been previously reported that elderly patients with CRC increase rather than decrease 
contact with primary care providers after diagnosis which continues through the first 5 years 
after cancer diagnosis. (Dobie, Saver, Wang, Green, & Baldwin, 2011) However, this still does 
not fully explain the reason for lack of survival benefit seen in those with the highest frequency 
of office visits. This is an avenue for further research that needs to be explored 
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Emergency surgery for CRC can have a significant impact on the progression of the 
disease. Predictors of emergency surgery such as race, and tumor location, must be explored 
further to avoid the burden associated with the condition. Stage at diagnosis is significantly 
associated with emergency surgery; which can be avoided by earlier diagnosis of the cancer. 
Further investigation into the association between tumor location and emergency condition for 
CRC surgery is warranted. 
Diabetes has a poor effect on the survival and all-cause mortality of patients with CRC. 
Emergency admission and stage at diagnosis has a large effect on survival and therefore 
underscore the importance of early diagnosis. Diabetic patients should be screened and 
diagnosed in a timely fashion to prevent CRC or have a better disease prognosis.   
This study points to a greater need for further investigation in the differential prevalence 
of colorectal tumor location in the elderly. Tumor location in diabetics must be studied further 
with a focus on detecting proximal tumors at earlier stages. Future studies should also investigate 
use of screening methods and their association with tumor location in the colorectal region and 
how it affects outcomes such as survival and mortality. 
Current screening guidelines do not consider diabetics as a special case for earlier 
screening or more frequent CRC screening. McBean and Yu have reported that elderly diabetic 
women are less likely than elderly non-diabetic women to receive colorectal cancer screening in 
the 11 SEER areas studied between 1999-2002. (McBean & Yu, 2007) They have furthered the 
argument in favor of altering CRC screening guidelines for diabetics by mentioning that the 
American Diabetes Association (ADA) should include specific screening recommendation for 
such cancers in the Standards of Medical Care in Diabetes. They also suggest combining specific 
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recommendations for people with diabetes in guidelines from federal or national organizations 
that promote the use of screening services but are not primarily or uniquely concerned with 
diabetes such as the CDC, the National Cancer Institute, the American Cancer Society, and the 
CMS. An example of such joint advocacy leading to success in the promotion of preventive 
services among people with diabetes was the effort to encourage influenza and pneumococcal 
immunization. During the 1990s, the CDC, the CMS, and the ADA all stressed that elderly 
individuals with diabetes should be vaccinated. As a result, in 2001, rates of influenza and 
pneumococcal vaccination were higher in individuals with diabetes 65 years or older compared 
with the total elderly population.  
Colorectal cancer can be prevented by timely screening. Since diabetic CRC patients 
have worse outcomes than their nondiabetic counterparts they must take advantage of this fact 
and prevent further burden associated with the disease. Combining the efforts of healthcare 
providers, policy makers and intervention strategies the frequency and timeliness of screening 
can greatly be improved.  
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